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  ABSTRACT 
Aerobic interval training, a form of high intensity interval training, is commonly 
prescribed to both the general and clinical populations. However, the acute physiological effects 
from a single bout of aerobic interval session are not fully understood. In training studies, these 
acute physiological effects may confound actual training adaptations when they occur following 
the final training session [1]. Furthermore, while recreationally active men perceived aerobic 
interval training to be more enjoyable than continuous moderate-intensity exercise [2], the 
preference of overweight and obese individuals has not been extensively researched. Since 
overweight and obese individuals tend to have lower exercise tolerance, it is possible that their 
perceived enjoyment may differ to recreationally active participants. Thus, the aim of this study 
was to examine the physiological effects and perceived enjoyment of an acute bout of aerobic 
interval (AI) and a continuous moderate-intensity (CME) in an overweight and obese population. 
In a randomised and counterbalanced order, eight overweight/obese (waist: 103 ± 10 
cm) participants performed bouts of CME (40 min at 50% of peak power output (PPO)) 
and AI cycling (13 x 1 min at 85% of PPO: 13 x 2 min at 30% of PPO). CME and 
AI were matched for duration and total work performed. Salivary cortisol was measured before, 
10 and 30 min post exercise and analysed using standard enzyme-linked immunosorbent assay 
kits. Blood pressure (BP), blood metabolites (glucose and lipid), insulin and resting 
metabolism were measured at baseline, post 24, 48 and 72 h exercise trials in a fasted and rested 
state. Peripheral BP was measured in duplicate using a manual sphygmomanometer and central 
BP and its associated hemodynamic parameters were derived from the radial pulse wave using 
a sphygmocardiogram (SphygmoCor). Resting metabolic profile was determined from gas 
exchange (TrueOne® gas analyser) measured in a supine and rested state over 40 min. 
Anthropometric (waist and hip circumferences and body composition) measurements were taken 
at baseline and at post 72 h after the last exercise trial. Participants completed the Physical 
Activity Enjoyment Scale (PACES) at the end of each trial.  
Salivary cortisol expressed as a percentage of baseline level increased in both trials and 
was significantly (mean ± SD) 189 ± 35% (p < 0.05) higher at 30 min post exercise. Resting 
brachial diastolic BP was lower in the AI trial compared with CME trial (82 ± 5 vs. 84 ± 5 
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mmHg respectively, p < 0.05). Resting brachial diastolic BP was lower than baseline (86 ± 12 
mmHg) at 24 h (83 ± 5 mmHg, p < 0.05) and at 72 h (82 ± 5 mmHg, p < 0.05) post exercise, 
however, there was no significant interaction between exercise trials and time points (p = 
0.07). Resting brachial mean arterial pressure was lower than baseline (102 ± 14 mmHg) at 24 h 
(99 ± 6 mmHg, p < 0.05), 48 h (98 ± 6 mmHg, p < 0.05) and 72 h (98 ± 6 mmHg, p < 0.05) post 
exercise. Resting brachial mean arterial pressure was also lower in the AI trial compared with 
CME trial (98 ± 6 vs. 100 ± 5 mmHg respectively, p < 0.05), however, there was no significant 
interaction between exercise trials and time points (p = 0.07). Derived resting aortic diastolic BP 
was lower in the AI trial, compared with the CME trial (83 ± 5 vs. 85 ± 5 mmHg respectively, p 
< 0.05). Compared with baseline (87 ± 4 mmHg), derived resting aortic diastolic BP was lower 
at 24 h (83 ± 5 mmHg, p < 0.05) and 72 h (82 ± 5 mmHg, p < 0.05) post exercise. No significant 
interaction effects were observed for derived resting central diastolic BP (p = 0.10). Derived 
resting mean aortic pressure was lower in the AI trial, compared with the CME trial (98 ± 6 
mmHg vs. 100 ± 5 mmHg, respectively, p < 0.05). Compared with baseline (102 ± 5 mmHg), 
derived resting mean aortic pressure was lower at 24 h (99 ± 6 mmHg, p < 0.05), 48 h (98 ± 6 
mmHg, p < 0.05) and 72 h (98 ± 6 mmHg, p < 0.05) post exercise. There was a trend towards 
interaction effects for resting derived mean aortic BP, however significance was not reached (p = 
0.063). Resting carbohydrate oxidation rate was higher than baseline (0.10 ± 0.06 g/min) at 72 h 
post exercise (0.16 ± 0.02 g/min), with no significant difference observed between trials. PACES 
scores were significantly higher for the AI than the CME trial (109 ± 13 vs. 96 ± 10).  
The main finding from this study is that a single AI and CME session can elicit acute 
physiological effects that last up to 72 h, with no significant difference observed between 
conditions. Significant decrements in diastolic and mean arterial pressures were observed up to 
72 h and resting carbohydrate oxidation rate was significantly higher 72 h following exercise. 
Therefore, training studies should look at scheduling post study measurement sessions more than 
72 h after the last exercise session bout to avoid confounding acute physiological effects with 
training adaptations. Finally, the study has also demonstrated that overweight/obese males enjoy 
the AI session more than the CME session. 
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CHAPTER ONE  INTRODUCTION 
In developed countries with a high national income and aging population, 
physical inactivity is established as one of the major risk of mortality [3, 4]. 
Furthermore, its detrimental effect is not isolated, as physical inactivity increases the 
risk of other mortality factors, such as high blood pressure, elevated blood glucose and 
obesity, all of which are associated with many chronic diseases such as cardiovascular 
diseases and cancer [4-10]. The incidence of physical inactivity also has significant 
negative social and economic impacts. In Australia, the total direct cost attributable to 
obesity, as defined by both waist circumference and body mass index (BMI), amounted 
to $21 billion in 2005 [11]. Since prevalence of obesity in Australia is projected to 
increase by 65% in 2025, obesity attributed cost will likely to increase in tandem [12].  
However, physical activity can lead to a 32% reduction in mortality [5] and a 2.5% 
reduction in global physical inactivity can avert an estimated 1.3 million deaths annually 
[13]. Collectively these data clearly show that physical activity is essential in 
maintaining general health and reducing mortality risk, which translates to reduction in 
health costs associated with ageing. Indeed, exercise has been established as one of the 
most cost-effective strategies for the prevention and management of several chronic 
diseases, including diabetes, cardiovascular disease (CVD) and some cancers.  
Many international and national agencies have outlined exercise prescription 
guidelines to encourage healthy active living [14-17]. While these guidelines vary 
slightly between countries, they generally convey the analogous message of encouraging 
individuals to engage in regular moderate-intensity physical activity between 30 to 60 
min on most if not all days [18]. However, these guidelines are often voluminous and 
difficult for some individuals to commit to. Supporting this, the most commonly cited 
barrier against exercise engagement and adherence is a lack of time [19-22]. There has 
recently been a paradigm shift in exercise recommendation from the sole emphasis on 
exercise volume towards the additional consideration of exercise intensity. Indeed, the 
increasing body of research highlighting the benefits of vigorous intensity physical 
activity [23-25] has prompted the American College of Sports Medicine (ACSM) and 
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American Heart Association (AHA) to advocate it explicitly in their physical activity 
guidelines [14].  
High-intensity interval training (HIIT) allows participants to perform cumulative 
vigorous bouts of exercise and is characterised by intermittent periods of work and rest. 
The contribution from anaerobic and aerobic energy systems vary with the duration and 
number of work bouts performed and the recovery between bouts. For the purpose of 
this thesis, HIIT protocols will be broadly classified into sprint (i.e. 10 – 30 sec “all-out” 
maximal work) interval (SIT) and aerobic (i.e. 80% - 100    O2max) interval (AIT) 
training protocols. While HIIT may result in rapid favourable adaptations, the high-
intensity nature of HIIT protocols especially those involving “all-out” sprints may be 
unsafe, impractical and thus unsuitable for many untrained, unhealthy or ‘at risk’ 
individuals [26]. Indeed, poor cardiovascular health of overweight and obese individuals 
may increase the risk of acute cardiovascular accidents during HIIT in these individuals 
[27-30]. Despite this, HIIT, especially AIT has been previously prescribed to various 
clinical populations with reports of favourable skeletal, cardiac and endothelial 
adaptations, resulting in improvements in blood lipid profile and blood glucose, aerobic 
capacity and exercise performance [1, 31-35].  
These favourable adaptations can occur after as little as two weeks of HIIT (i.e. 
either AIT or SIT) [1, 26, 36]. Although training adaptations resulting from long term 
adoption of AIT have been extensively studied, our understanding of the acute 
physiological responses to a single session of AIT is limited. The acute physiological 
responses following a training intervention have previously been termed ‘last exercise 
bout’ effects [37]. Understanding these responses is important as they can confound 
actual training adaptations, especially following short term intervention studies [1]. 
Furthermore, prolonged physiological effects after an acute exercise intervention may 
convey transient favourable health benefits which can be accumulative if the exercise 
modality is performed over multiple sessions [37]. As such, detailed understanding of 
the acute physiological effects and stress induced by AIT may aid in improving exercise 
program prescription in athletic, general and clinical populations. 
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Cortisol is an adaptive endocrinal response towards both physical and mental 
stress [38]. It is responsible for substrate mobilisation during increased metabolic 
demands [39] and partly explains stress-induced metabolic and physiological adaptations 
[40, 41]. Both exercise duration and intensity significantly influence cortisol secretion 
during and following exercise [42-44]. In comparison to lean individuals, overweight 
and obese participants have previously been reported to have an elevated cortisol 
response following exercise [45]. However, we are currently unaware of any studies that 
have examined post exercise cortisol response after a single aerobic interval (AI) session 
in overweight and obese individuals. These individuals are at greater risk of developing 
metabolic diseases; therefore cognizance of any favourable acute physiological 
responses to a single bout of AI session would help further contribute to better exercise 
prescription. Exercise intensity plays a crucial role in exercise adherence [46]. Indeed, it 
has previously been found that the prescription of exercise at an intensity greater than 
the preferred intensity diminish enjoyment of exercise in overweight individuals [47]. 
Hence, while AIT may be a potential alternative to the conventional continuous 
moderate-intensity exercise (CME), it is possible that such exercise may be less 
preferred by certain clinical populations. Conversely, prospective findings from Bartlett 
et al. (2011) show that recreationally active men perceived AIT to be more enjoyable 
than CME, indicating that it may be an ideal exercise model that encourages exercising 
at higher intensities without compromising on perceived enjoyment [2]. However, Sim, 
Wallman, Fairchild and Guelfi (2014) reported that overweight individuals perceived 
similar enjoyment from both AI and CME [48]. This indicates that perceived enjoyment 
of AIT differs between recreationally active and overweight individuals and is 
diminished in the latter. Therefore, further research is needed in order to better 
understand the acute physiological responses to AIT and the perceived enjoyment of 
such exercise in overweight individuals. 
1.1 Purpose 
The primary objective of this thesis was to examine and compare the influence 
single bouts of aerobic interval and continuous moderate-intensity exercise have on 
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fasting blood lipid and glucose profiles, insulin, resting central and peripheral blood 
pressures, resting metabolism (i.e. metabolic rate, energy expenditure and 
lipid/carbohydrate oxidation rates) and measurements of body composition (i.e. lean, fat 
and bone tissue masses) over a 72 h post exercise period in overweight and obese 
individuals. A secondary purpose of this study was to compare the post exercise (i.e. 10 
and 30 min) salivary cortisol response between aerobic interval and continuous 
moderate-intensity cycling performed by overweight and obese individuals. The final 
objective of the study was to determine and compare the perceived enjoyment of single 
bouts of aerobic interval and continuous moderate-intensity cycling in overweight and 
obese individuals. 
1.2 Research Questions 
i. What influence does single bouts of aerobic interval and continuous 
moderate-intensity cycling have on fasting blood lipid, glucose and insulin 
profiles, resting central and peripheral blood pressures and its associated 
parameters and resting metabolism in overweight and obese individuals in the 24 
h, 48 h, and 72 h following exercise. 
ii. Is there a difference in post-exercise (i.e. 24 h, 48 h, and 72 h) fasting 
blood lipid, glucose and insulin profiles, resting central and peripheral blood 
pressures and its associated parameters and resting metabolism following aerobic 
interval and continuous moderate-intensity cycling in overweight and obese 
individuals. 
iii. Is there a difference in post-exercise salivary cortisol response between 
single bouts of aerobic interval and continuous moderate-intensity exercise in 
overweight and obese individuals? 
iv. Is there a difference in perceived enjoyment between single bouts of 
aerobic interval and continuous moderate-intensity exercise in overweight and 
obese individuals? 
 5 
1.3 Abbreviations of Selected Terms 
 
AIT aerobic interval training 
AI aerobic interval session 
BMI body mass index 
BPM beats per min 
CDBP derived aortic diastolic blood pressure 
CMAP derived mean aortic pressure 
CME continuous moderate exercise 
CSBP derived aortic systolic blood pressure 
DBP diastolic blood pressure (brachial) 
DEXA dual-energy X-ray absorptiometry 
HDL high density lipoprotein 
HIIT high-intensity interval training 
HOMA homeostatic model assessment 
HR heart rate 
LDL low density lipoprotein 
MAP mean arterial pressure (brachial) 
MCHO carbohydrate oxidation rate 
Mlipid lipid oxidation rate 
OGTT oral glucose tolerance test 
PACES physical activity enjoyment scale 
PAR-Q physical activity readiness questionnaire 
PPO peak power output 
REE resting energy expenditure 
RER respiratory exchange ratio 
RMR resting metabolic rate 
RPE rating of whole body perceived exertion 
SBP systolic blood pressure (brachial) 
SI sprint interval session 
SIT sprint interval training 
  O2peak   O2max peak/maximal oxygen consumption 
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CHAPTER TWO  LITERATURE REVIEW 
 2.1 Physical Inactivity and its Implications 
In 2004, physical inactivity was identified as the fourth leading risk factor of 
mortality, contributing to 6% in global mortality [4]. However, physical inactivity does 
not elicit an isolated effect but also modifies other metabolic risks factors such as 
increased blood glucose, elevated blood pressure and obesity [10]. These in turn increase 
the risk of many chronic diseases, such as coronary heart disease, type 2 diabetes and 
various cancers [5-9]. The increased prevalence of physical inactivity has been largely 
attributed to rapid urbanisation, industrial mechanisation and use of mechanised 
transport [3, 49]. In 2012, 31.1% of adults globally were physically inactive with 
prevalence greatest in countries with a high average income and an aging population [3]. 
Physical inactivity not only negatively influences health but also has significant social 
and economic impacts. For example, in Canada, physical inactivity costed the economy 
$6.8 billion in 2009, which equates to about ~3.7% of the total health care cost [50]. In 
Australia,  health care cost of sedentary middle-aged women was reported to be 26.3% 
greater than those who were moderately active [51]. This is a pressing issue as a recent 
population study revealed that more than half of Australians are either sedentary or 
reported low level of physical activity [52]. Fortunately, physical inactivity is a 
modifiable behavioural risk factor. On a global scale, a reduction in physical inactivity 
by 2.5% can avert an estimated 1.3 million deaths every year [5]. For an individual, 
becoming physically active can confer a 32% reduction in risk of all-caused mortality 
[13]. Clearly, increasing the level of physical activity of the general population is 
therefore pertinent in improving a variety of health, economic and social outcomes. 
2.2 The Undefined “Optimal” Exercise Dose 
To address the increasing prevalence of physical inactivity, several international 
and national agencies have developed guidelines to encourage physical activity. Most of 
these conventional guidelines endorse the daily engagement in moderate-intensity 
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physical activity for a minimum duration, varying between 30-60 min [18]. The 
rationale behind these guidelines was based on findings that demonstrated a clear 
association between accumulated total or weekly caloric expenditure and cardiovascular 
mortality [18, 19]. However, there are studies in the literature suggesting that exercise 
volumes lower than the conventional minimum recommendation may be sufficient to 
elicit a reduction in health risks [53-55]. For example, Wen et al. (2011) suggested that 
health benefits may be accrued with as little as 15 min of moderate-intensity exercise 
[56]. Indeed, the volume, frequency and intensity of physical activity may all 
significantly influence the adaptations and consequential health benefits of exercise, 
with the best possible permutations of these factors yet to be clearly established [55, 57]. 
Therefore, while previous research has clearly presented a strong dose-response 
relationship between physical activity and health benefits, the specifics of this 
relationship remains largely undefined [13]. On the premise that the total energy 
expended through physical activity is partly mediated by exercise intensity, it has been 
suggested that exercise intensity plays an influential role in the dose-response 
relationship between physical activity and health benefits. Regular participation in 
vigorous intensity physical activity and the associated greater energy expenditure has 
been associated with decreased mortality and cardiovascular related morbidity and a 
healthier state of being when compared with lower intensity exercise [25, 58, 59]. 
Consequentially, there has been a paradigm shift in exercise recommendations with 
added emphasis on exercise intensity apart from total exercise volume [23-25, 60]. Such 
a change in consensus was reflected in the update to the American College of Sports 
Medicine (ACSM) and American Heart Association (AHA) physical activity guidelines 
in 2007 which explicitly included recommendations on the participation of vigorous-
intensity physical activity [14].  
Independent of the volume (i.e. duration) spent engaged in the physical activity; 
there is also evidence to suggest that exercise intensity can confer a reduction in risk of 
chronic diseases. For instance, it has been reported that high-intensity physical activity 
of ≥ 6 metabolic equivalents (METs), independent of exercise volume, was associated 
with lower relative risk of coronary heart disease (CHD) compared to both moderate-
intensity (4 – 6 METs) and lower-intensity (1 – 4 METs) exercise [59]. Within this study 
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every increment of 1 MET was accompanied by a 4% reduction in CHD risk [59]. This 
research is supported by isocaloric training studies, which have found that high-intensity 
exercise (i.e.  0 –  0     O2peak) training results in greater improvements in 
cardiovascular fitness, glucose tolerance, blood lipid profile and blood pressure when 
compared with moderate-intensity exercise (i.e.  0 – 60    O2peak) training [61, 62]. As 
such, the observed benefits are not simply the result of an increase in total training load 
(i.e. volume and intensity) but instead may be caused by the high-exercise intensities per 
se. These observations highlight that individuals can maintain a healthy state of being 
with lower time commitment by regular participation of vigorous-intensity physical 
activity. This is important since ‘lack of time’ is a commonly cited barrier against 
exercise adherence and participation in physical activity [19-22].  
Studies such as that published by Talanian, Galloway, Heigenhauser, Bonen and 
Spriet (2007) which reported training adaptations comparable to those observed in 
longer duration endurance type training studies from just 2 weeks of aerobic interval 
training, prompted further research on high-intensity interval exercise modality as a 
time-efficient alternative against the traditionally recommended continuous moderate-
intensity exercise modality [36]. In fact, studies comparing between both these 
modalities have reported greater if not comparable favourable metabolic adaptations 
after high-intensity interval training despite having controlled for or a marked difference 
in total exercise volume [33, 63-65]. Therefore, the following sections of this chapter 
will review the current body of literature relating to the possible benefits of high-
intensity exercise. This literature will be discussed in comparison with traditional 
continuous moderate-intensity training and within the context of its application in both 
the general and clinical populations. 
2.3 High-intensity Interval Training (HIIT) 
High-intensity interval training (HIIT) is an exercise modality which is 
characterised by repetitions of short high-intensity work interspersed with bouts of low-
intensity exercise or complete rest. Due to the intermittent nature of most sports and the 
ability of HIIT to rapidly improve performance this modality has been commonly 
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utilised in athletic populations [66-69]. Numerous factors may be altered within HIIT in 
order to vary the exercise stimulus and adaptation, including exercise and recovery 
modality, exercise intensity and work-rest ratio duration. As a result, considerable 
possible combinations exist for HIIT. Therefore, for the purpose of this literature review, 
the discussion on HIIT will be limited to sprint interval training (SIT) and aerobic 
interval training (AIT). The protocol for a typical SIT session usually involves 4 - 6 sets 
of 10 - 30 seconds “all-out” sprints, interspersed with 4 - 4.5 min of complete rest or 
low-intensity recovery [1, 70-73]. In contrast, AIT is typically characterised by longer 
periods (i.e. 1 - 4 min) of high-intensity exercise (i.e.  0  -  00  of   O2max, HRmax or 
HRR) interposed with similar periods (e.g. 1 - 4 min) of rest, performed over 4 or more 
sets [70, 74]. The contrast between a SIT and AIT is defined by the difference in the 
contribution from each energy system during exercise. The short supra-maximal work 
intervals during SIT results in a high anaerobic energy demand, rapidly impairing 
phosphocreatine and anaerobic glycolytic pathways and aerobic energy demand 
increases with the increasing number of intervals [68, 75, 76]. However, the lower 
exercise intensity (i.e. at or near maximal aerobic power or velocity at   O2max) and 
longer interval duration of the AIT results in considerable contribution from aerobic 
system throughout each effort [66, 77]. Due to the high-intensity and very short duration 
of SIT many of the observed adaptations have been observed in the periphery (i.e. 
muscle). Indeed, SIT has been shown to elicit an upregulation of key intramuscular 
regulatory enzymes of all three energy systems (i.e. creatine kinase, phosphofuctokinase 
and citrate synthase), enhancing oxygen utilisation [66, 78]. Furthermore, SIT can also 
elicit muscular morphological changes such as muscular hypertrophy, a bidirectional 
shift in muscle fibre towards type IIa and improve muscle contractile characteristics via 
an increase in the volume of the sarcoplasmic reticulum [78]. Conversely, AIT has been 
shown to result in significant central (i.e. cardiac output) and peripheral adaptations [73, 
79, 80]. For instance, improvement in aerobic capacity in tandem with an increase in left 
ventricle end diastolic volume and the resultant stroke volume was observed after 13 
weeks of AIT in obese adolescents [79] and enhancement in key intramuscular 
regulatory enzymes associated with anaerobic glycolytic and aerobic energy systems 
was observed after 6 weeks of AIT in recreationally active individuals [81]. The premise 
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for the prescription of HIIT, in untrained and clinical populations lies within the work-
rest interval bouts which exposes individuals to intermittent bouts of high cellular stress 
over extended periods, thereby allowing for greater adaptations than would be possible 
with steady state exercise [70, 82]. Importantly, HIIT has been safely prescribed to a 
number of clinical populations (i.e. individuals with type two diabetes, metabolic 
syndrome, post-myocardial infarction), despite the concern for an increased risk of acute 
cardiovascular accidents [1, 30-35, 83-86]. Therefore, the following sections of the 
review examine the literature pertaining to the intramuscular, metabolic and health 
benefits of HIIT in order to illustrate how HIIT can be used as an alternative exercise 
intervention to the traditional continuous moderate-intensity modality. 
2.4 Metabolic adaptations from HIIT in both healthy and clinical 
populations 
Skeletal muscle fibres are extremely adaptable to physiological stress. 
Neurological, morphological and metabolic adaptations can occur in response to 
exercise training resulting in enhanced skeletal muscle work capacity [78, 87]. In this 
section, we will limit the discussion to metabolic adaptations occurring in response to 
HIIT. Observed intramuscular metabolic adaptations in response to HIIT includes an 
increase in the protein content and activity of key regulatory metabolic enzymes, 
increase in intramuscular substrate availability and its delivery and lastly, improvement 
in its buffering capacity [66, 78]. 
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC- α) 
is considered a ‘key regulator’ of several transcriptional factors that are associated with 
adaptive thermogenesis, fibre type switching in skeletal muscle, mitochondrial 
biogenesis, cellular metabolism and heart development [88]. The expression of PGC-1α 
after exercise is activated through several upstream signalling pathways including 
Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) and calcineurin A (CnA) (i.e. 
calcium-mediated signalling via nerve stimulation) [89, 90], p38 mitogen-activated 
protein kinase (p38 MAPK) [91] and AMP-activated protein kinase (AMPK) (i.e. when 
AMP:ATP ratio is high) [92]. Numerous studies have shown that PGC- α , along with 
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downstream markers of mitochondrial biogenesis and both lipid and glucose oxidation, 
may be upregulated following AIT and SIT  [26, 32, 33, 65, 93, 94]. For instance, a brief 
(i.e. 1 week, 3 sessions per week) period of SIT resulted in a significant increase in the 
protein content of the mitochondrial enzyme cytochrome c oxidase subunit IV (COX IV) 
and the cellular glucose transporter GLUT IV, which will improve cellular glucose 
utilisation and oxidative capacity [95]. However, within this study no training effect was 
observed in lipid transporters (i.e. fatty acid translocase and fatty acid binding protein) 
[95]. Furthermore, 6 to 7 weeks of SIT can increase hexokinase (HK), 
phosphofructokinase (PFK), citrate synthase (CS) [96],  pyruvate dehydrogenase (PDH) 
and β-hydroxyacyl-CoA-dehydrogenase (β-HAD) [65], which will improve both glucose 
and lipid oxidative capacities. Alternatively, 2 weeks of AIT in healthy individuals has 
been shown to upregulate the enzymatic activity of CS [26, 36] and elicit an increase in 
the protein content of COXII, COXIV, GLUT IV [26] as well as an increase in fatty acid 
binding protein with no increase in fatty acid translocase [36]. Longer AIT (i.e. 20 
weeks) in healthy individuals has also been shown to result in significant increases in the 
activity of other enzymes involved in both glycolytic and oxidative pathways (i.e. HK, 
PFK, malate dehydrogenase (MDH) and β-HAD) [97]. Collectively these studies 
indicate that both AIT and SIT are effective in activating cell signalling cascades that 
ultimately improve the oxidative and metabolic capacity of muscle.  
Furthermore, while there are extant AIT studies on intramuscular metabolic 
adaptations in the clinical population, to the best of the author’s knowledge, there are no 
existing SIT studies which have observed for these adaptations in this population. The 
beneficial effects of HIIT are not limited to healthy populations. Indeed, AIT has been 
shown to be effective in enhancing aerobic enzymatic activity and increasing protein 
content of PGC-1α, COX I, II and IV and GLUT IV and in a variety of clinical 
populations including type 2 diabetics, patients with medically treated post-infarction 
heart failure and overweight and obese individuals [31-33, 94]. These results are 
important since many of these markers have been implicated the development or 
progression of chronic diseases. For instance, citrate synthase activity (i.e. indicator of 
mitochondria content) is reduced in obese insulin resistant individuals and type 2 
diabetics [98-100], thus exercise induced increase in expression and content of PGC-1α 
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leading to mitochondria biogenesis may assist in the treatment and prevention of 
metabolic syndrome.  Collectively, these studies have shown that HIIT can induce 
favourable intramuscular metabolic adaptations in both healthy and clinical populations. 
Specifically, both AIT and SIT can enhance intramuscular oxidative capacity and 
improve glucose utilisation, however it seems that while AIT can improve intramuscular 
lipid oxidation and utilisation, the effect that SIT has on lipid utilisation requires more 
research.  
2.5 Cardiometabolic benefits from high-intensity interval training in both 
healthy and clinical populations 
Undesirable metabolic and physiological changes are corollary to assuming a 
more sedentary lifestyle and together with environmental factors such as increased 
availability of food can strongly condition the obesity phenotype [4, 101]. A chronic 
state of obesity may result in a pre-morbid state, known as metabolic syndrome, which is 
usually characterised by a large waist circumference, dyslipidaemia, glucose intolerance, 
hypertension, low grade inflammatory and prothrombotic states [102, 103]. Metabolic 
syndrome predisposes an individual towards greater risks of developing related co-
morbidities such as type II diabetes and cardiovascular diseases [104, 105]. This section 
will further illustrate how HIIT can elicit favourable systemic physiological adaptations, 
thus attenuating metabolic risk factors. 
2.5.1 Aerobic capacity and exercise tolerance 
In both clinical and healthy individuals, short term (i.e. 2 – 3 weeks) AIT and 
SIT have been shown to increase aerobic capacity [1, 36, 83, 106].  or instance,   weeks 
of AIT (i.e. 4 min at  0  of   O2peak interspersed with 2 min rest, 13 sessions) increased 
absolute   O2peak by 13% in recreationally active women [36]. In patients with severe 
chronic heart failure, 3 weeks of AIT (i.e. cycling: 30 sec at 50% peak power output 
(PPO) interspersed with 60 sec at 15 W, 5 times a week, treadmill walking: 60 sec at 2.4 
mph interspersed with 60 sec at 0.9 mph, 3 times a week) increased relative   O2peak by 
20% [83]. Following 2 – 3 weeks of progressive  IT, relative  O2max increased by 5% in 
recreationally active individuals [106] and absolute   O2peak increased by 8.4% in 
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overweight/obese individuals [1]. Likewise, long term AIT (i.e. 4 weeks to 6 months) 
[32-34, 64, 84, 94, 107, 108] and SIT (i.e. 4 – 15 weeks) [35, 73, 96, 106, 109-111] 
studies also reported improvement in aerobic capacity. Importantly, improvement in 
aerobic fitness is a favourable adaptation, since it is a robust indicator of all-cause 
mortality [112-115]. Furthermore, in some SIT and AIT studies, an increase in exercise 
tolerance is concomitant with improvement in aerobic capacity [35, 36, 83]. For 
instance, after two weeks of AIT (i.e. 4 min at  0  of   O2peak interspersed with 2 min 
rest) with improvement in aerobic capacity, recreationally active women responded to a 
similar 60 min cycling trial ( 60  of   O2peak) at a lower percentage of their   O2peak, 
with increased fat oxidation rate, reduced carbohydrate oxidation rate and with both 
lower HR and plasma epinephrine levels [36]. The attenuated epinephrine indicates a 
reduced sympathetic response towards the similar workload following training resulting 
in a lower HR response and reduction in glycogenolysis that is supported by the changes 
in substrate utilisation [116, 117]. Similarly, two weeks of SIT in healthy individuals 
improved relative aerobic capacity and responded to a similar workload (i.e.   h at 6   
of   O2peak) with reduced absolute oxygen consumption and carbohydrate utilisation in 
tandem with an increase in lipid oxidation rate [118]. Notably, in patients with stable 
chronic heart failure, an increase in exercise tolerance was evident by the similar HR, 
blood pressure (BP) and whole body rating of perceived exertion (RPE) responses 
despite increase training workload. 
2.5.2 Cardiovascular adaptations and improvements in hemodynamic parameters  
Improvement in aerobic fitness may partially explained by favourable 
cardiovascular adaptations. Both SIT and AIT studies have reported concomitant 
improvement in endothelial function with the observed improvement in aerobic fitness 
in both healthy and clinical populations [32, 33, 84, 94, 107, 110]. This improvement 
may be partly explained by an increase in plasma nitric oxide observed in two of the 
AIT studies [33, 84]. The literature also suggests that AIT can reduce the risk of 
coronary artery disease. For instance, oxidised low density lipoprotein (LDL), a 
sensitive marker for coronary artery disease was markedly reduced after 4 months of 
AIT (i.e. 4 min at 90% of HRmax interspersed with 3 min at 70% of HRmax, 3 sessions a 
 14 
week) in individuals with metabolic syndrome [33]. However, this finding is not 
observed in all studies, thus further research is warranted [84, 94]. Furthermore, AIT and 
SIT can also significantly lower blood pressure (BP). For instance, long term AIT can 
favourably lower both systolic [33, 84, 107] and diastolic [33, 84, 94, 107] BP. For 
instance, 4 months of AIT (i.e. 4 min at 90% of HRmax interspersed with 3 min at 70% 
HRmax, 3 sessions a week) decreased systolic BP (144 ± 5 vs. 135 ± 5 mmHg), diastolic 
BP (i.e. 95 ± 3 vs. 89 ± 3 mmHg) and mean arterial pressure (MAP) (i.e. 111 ± 3 vs. 105 
± 3 mmHg). Alternatively, 2 to 6 weeks of SIT can decrease systolic BP in both 
adolescents [119] and overweight/obese individuals [1]. For instance, 7 weeks of SIT 
(i.e. progressive increment from 4 sets of 20 maximal sprint running interspersed with 
20 – 30 sec of active recovery, 3 sessions a week) decreased systolic BP (112 ± 10 vs. 
106 ± 11 mmHg) in adolescents [119]. However, Rakobowchuk et al., 2008 did not 
observe any changes in brachial BP following 6 weeks of SIT (i.e. progressive increment 
from 4 sets of 30 sec maximal “all-out” sprints interspersed with 4.5 min of cycling at 30 
W) in healthy individuals [110]. While short term studies suggest that SIT can lower 
systolic BP, longer term studies are warranted to elucidate if it can lower both systolic 
and diastolic BP. Lastly, favourable cardiac remodelling such as reverse left ventricular 
remodelling resulting in reduced end diastolic and systolic volumes and a greater left 
ventricular ejection fraction from 12 weeks AIT (i.e. 4 min at 90 – 95% of HRpeak, 3 min 
at 70% of HRpeak, 3 sessions a week) have been observed in patients with post infarction 
heart failure [32]. In fact, further insights can be observed from isolated cardiomyocytes 
from rats and mice extracted after AIT. 4 – 6 weeks of AIT can induce distinctive 
adaptations (i.e. balanced hypertrophy, improved contractility and intracellular calcium 
handling and enhanced myofilament calcium sensitivity) in cardiomyocytes [120-122]. 
Notably, AIT intervention studies involving patients with previous history of 
cardiovascular diseases (i.e. chronic heart failure and coronary artery disease) suggests 
that AIT can be safely prescribed to those who are at risk of developing cardiovascular 
diseases. No studies have yet to examine the efficacy of SIT in cardiac rehabilitation, 
possibly due to its supramaximal intensity, making it unsuitable for cardiac 
rehabilitation. 
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2.5.3 Anthropometric and body composition  
Obesity is associated with increased risk of developing both type 2 diabetes and 
cardiovascular diseases [123, 124]. Therefore, an important objective for obese 
individuals or those with metabolic syndrome is improvement in body composition. 
Weight loss and reduction in waist circumference can reduce the related risks for these 
individuals [125, 126]. Long term (i.e. 3 – 12 months) studies observed significant 
reduction in body fat percentage in overweight [94], healthy [97] individuals and 
adolescents [84] after AIT intervention. For example, 3 months of AIT (i.e. 4 min at 85-
95% of HRmax, 3 min at 50-60% of HRmax) resulted in a 2% reduction in body weight, 
reduction in BMI (i.e. 36.6 ± 1.2 vs. 36.0 ± 1.2 kg/m
2
) and 2.2% reduction in body fat in 
obese individuals [94]. However, Nybo et al. (2010) reported that 5 months of AIT (i.e. 
2 min at above 95% of HRmax, 1 min of passive rest, 2 sessions a week) did not result in 
any changes in lean body mass and body fat percentage in healthy individuals [63]. It is 
a possible that the lack of change in body composition in the study by Nybo at al. (2010) 
could be due to difference in participants’ demographics and training protocols. For 
instance, participants in Nybo et al. (2010) exercised for 20 min (includes warm-up and 
cool down) per session, twice a week, which is lower in training volume in comparison 
to the other studies, in which participants exercised more than 20 min per session, thrice 
a week [63, 84, 94]. Therefore, while AIT can improve body composition by reducing 
fat mass, the training duration plays a crucial role in determining its efficacy. Few SIT 
studies have examined changes in body composition, in a study by Buchan et al. (2011), 
body composition (i.e. body fat percentage) was not affected after 7 weeks of SIT (i.e. 
progressive increment from 4 sets of 20 maximal sprint running interspersed with 20 – 
30 sec of active recovery, 3 sessions a week) in adolescents [119]. However, Trapp, 
Chisholm, Freund and Boutcher (2008) reported that 15 weeks of SIT (i.e. progressive 
increment of 8 sec sprinting against 0.5kg followed by 12 sec of slow cycling over 15 
weeks) significantly reduced body mass, fat mass and trunk fat in health women [111]. 
The difference in both recruited populations and exercise protocols could have explained 
the disparity in findings between Buchan et al. (2011) and Trapp et al. (2008) however; 
it can also indicate that a longer period of SIT (i.e. 15 weeks) is needed before 
improvement in body composition can be observed. 
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Presence of abdominal obesity, as assessed by waist circumference is a criteria 
for the classification of metabolic syndrome by several health organisations [127]. 3 – 4 
months of AIT can reduce waist circumference in individuals classified with metabolic 
syndrome and overweight adolescents [33, 84, 107]. For instance, 3 months of AIT (i.e. 
4 min at 90-95% of HRpeak, 3 min at ~70% of HRpeak, 3 sessions a week) significantly 
reduced waist circumference (i.e. 109.6 ± 10 vs. 108.3 ± 10.7 cm) in those with 
metabolic syndrome. However, SIT effect on waist circumference is equivocal. For 
instance, in one study, 2 weeks of SIT in overweight/obese males significantly reduced 
both waist (i.e. 101.3 ± 2.7 vs. 98.9 ± 3.1 cm) and hip (i.e. 110.9 ± 2.2 vs. 109.8 ± 2.2 
cm) circumferences [1]. However, Buchan et al. (2011) did not observe any changes to 
waist-hip ratio after 7 weeks of SIT in adolescents [119]. Thus, AIT can elicit reduction 
in waist circumference, however more SIT studies are warranted to further investigate its 
efficacy in reducing waist circumference. 
At present, it appears that AIT is superior to SIT in eliciting favourable 
anthropometric and body composition changes; furthermore, longer duration SIT studies 
examining its efficacy in anthropometric and body composition changes are warranted. 
2.5.4 Glucose homeostasis 
Exercise is important in the management of glucose homeostasis in those with 
metabolic syndrome and type 2 diabetes. Extant studies show that short (i.e. 2 – 3 
weeks) [31] and long (i.e. 3 – 5 months) [33, 63, 84] term AIT can mitigate 
hyperglycaemia during fasting and under glucose loading in both healthy and clinical 
populations. For instance, 2 weeks of AIT (i.e. 60 sec at 90% of HRmax, 60 sec at 30 W, 
3 sessions a week) reduced average 24 h blood glucose concentration (i.e. 7.6 ± 1.0 vs. 
6.6 ± 0.7 mmol/L) and sum of the 3 h postprandial area under glucose curves for 
breakfast, lunch and dinner (i.e. 965 ± 483 vs. 679 ± 437 mmol/L.9 h) in type 2 diabetics 
[31]. Additionally, 5 months of AIT (i.e. 2 min at above 95% of HRmax, 1 min of passive 
rest, 2 sessions a week) reduced fasting glucose level (i.e. 5.7 ± 0.2 vs. 5.2 ± 0.1 mM) 
and glucose level after oral glucose tolerance test (OGTT) (i.e. 6.1 ± 0.6 vs. 5.1 ± 0.4 
mM) in healthy individuals [63]. However, a 3 month AIT (i.e. 4 min at 90-96% of 
HRpeak, 3 min at ~70% of HRpeak, 3 sessions a week) study by Stensvold et al. (2010) did 
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not improve insulin sensitivity, reduce fasting glucose levels and glycated haemoglobin 
(HbA1c) in individuals with metabolic syndrome [107]. Until others report can 
corroborate that reported by Stensvold et al. (2010), the literature indicates that AIT can 
improve glucose homeostasis. Studies suggest that SIT as short as 2 weeks up to 6 
weeks can improve insulin sensitivity [1, 109, 128, 129], while two of these studies 
reported no changes to fasting insulin and glucose [128, 129], Whyte et al. (2010) 
reported a reduction in fasting insulin after 2 weeks of SIT in overweight/obese 
individuals [1]. Trapp et al. (2008) also found a significant reduction in fasting insulin 
level following SIT (i.e. progressive increment of 8 sec sprinting against 0.5kg followed 
by 12 sec of slow cycling over 15 weeks) in healthy women [111]. Also, Metcalfe, 
Babraj, Fawkner and Vollaard (2012) reported gender specific improvement in insulin 
sensitivity such that insulin sensitivity improved by 28% only in males [109]. It appears 
that there are divergent findings on the efficacy of SIT in improving fasting glucose and 
insulin levels and more research is warranted, however it may improve peripheral insulin 
sensitivity under glucose loading. Improvement in peripheral insulin sensitivity under 
glucose load could have possibly resulted from the previously mentioned intramuscular 
enhancement in glucose utilisation and transport after SIT.  
2.5.5 Lipid metabolites  
Dyslipidemia is characterised by having elevated levels of triglycerides rich 
lipoproteins (VLDL) or remnants concentration of VLDL and low levels of high density 
lipoproteins (HDL) in the plasma [130]. It is associated with increased risk of 
cardiovascular diseases [131, 132] and is a criterion for the classification of metabolic 
syndrome proposed by several health institutions [127, 133, 134]. 3 – 4 months of AIT 
in both healthy [63] and overweight individuals [94] and those with metabolic syndrome 
[33, 107] did not result in any change to fasting triglycerides, HDL, total cholesterol and 
LDL levels. For instance, 3 months of AIT (i.e. 4 min at 90% of HRmax, 3 min at 70% 
HRmax) did not affect triglycerides, total cholesterol and low density lipoprotein (LDL) 
in those with metabolic syndrome [33]. However, Tjønna et al. (2009) reported a 
divergent decrease in HDL levels after 3 months of AIT in overweight adolescents [84]. 
This disparity could be a result of the difference in population recruited between studies.  
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Likewise, 2 weeks of SIT did not elicit any changes to fasting triglycerides, total 
cholesterol, HDL and non-esterified fatty acid (NEFA) in overweight/obese individuals 
[1]. Similarly, 7 weeks of SIT (i.e. progressive increment from 4 sets of 20 maximal 
sprint running interspersed with 20 – 30 sec of active recovery, 3 sessions a week) did 
not elicit any changes to HDL, LDL and total cholesterol levels in adolescents, however 
authors observed an increase in triglycerides. These studies indicate that both AIT and 
SIT may have negligible effects on lipid metabolites; however more research is 
warranted before it can be conclusive.  
2.6 Comparisons of metabolic adaptations and health benefits between 
HIIT and conventional CME protocols 
To fully appreciate the rationale behind the burgeoning interest in promoting 
high-intensity interval training as an alternative to the preferred conventional continuous 
moderate-intensity exercise (CME) modal, we have to draw insights from comparison 
studies between these two exercise modals. Existing comparison studies tend to feature 
two types of study designs. The first uses an isocaloric design, allowing exercise 
intensity to be the contrasting feature. It is used mostly in the comparison between CME 
and AIT. For instance, participants performing CME in Tjønna et al. (2008) had to cycle 
longer to equalise work volumes between protocols (i.e. AIT: 43 min, includes warm up 
and cool down vs. CME: 47 min) [33]. In another design, both energy expenditure and 
exercise duration are not controlled for to highlight the difference in time commitment 
and energy expenditure. It is used mostly for comparison between SIT and CME. For 
instance, in the study by Burgomaster et al. (2008), the weekly time commitment (i.e. 
SIT: 1.5 h vs. CME: 4.5 h) and total training volume (i.e. SIT: 225 kJ/week vs. CME: 
2250 kJ/week) between SIT and CME protocols differs markedly.  
2.6.1 Intramuscular metabolic and ion handling adaptations 
Impairment in calcium handling can contribute to cardiomyocytes dysfunction, 
conversely, improvement in calcium handling can enhance contractility and increase 
cardiac power output [135, 136]. Likewise, improvement to calcium handling in skeletal 
muscles can improve muscle function via an increase in rate of force production and 
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power output. It is demonstrated in animal models that AIT is superior over CME in 
enhancing intramuscular calcium handling [137, 138]. Likewise, in human studies, AIT 
enhanced reuptake of Ca
2+
 in the sarcoplasmic reticulum in skeletal muscles while no 
changes were detected after CME [32, 33, 94]. For instance, compared with CME (i.e. 
47 min at 70 - 75% of HRmax, 3 sessions a week), 3 months of AIT (i.e. 4 min at 90% of 
HRmax, 3 min at 70% of HRmax, 3 sessions a week) increased maximal rate of calcium 
uptake by sarcoplasmic reticulum calcium ATPase by 60% with no observed effect in 
the CME group and significant improvement to peak systolic mitral annulus velocity 
(i.e. an index of global contractility in the heart) by 22% with no observed effect in the 
CME group.. To the best of the authors’ knowledge, no study has yet to compare the 
effect of SIT with CME on skeletal muscle calcium handling and this warrants further 
study. Comparison studies between AIT and CME on changes to PGC- α protein levels, 
showed that between the two protocols, PGC- α protein levels increased only after AIT 
and not CME [32, 33, 94] and in two of these studies, energy expenditure between AIT 
and CME was similar [32, 33]. Furthermore, 6 weeks of SIT, despite having a lower 
training volume (i.e. SIT: ~225 vs. CME: 2250 kJ/week) and time commitment (i.e. SIT: 
1.5 vs. CME: 4.5 h/week) than CME, elicited similar marked increase in protein content 
of PGC- α to CME [65]. These findings suggest that with sufficiently high exercise 
intensity, training volume can be reduced to elicit similar mitochondrial biogenesis, 
therefore illustrates the time efficient characteristic of HIIT. In fact, the transcription of 
PGC- α is influenced by exercise intensity [139]. On this basis, improvement in 
intramuscular metabolic capacity should be greater after HIIT. Indeed, Tremblay, 
Simoneau and Bouchard (1994) observed that 20 weeks of AIT (i.e. 30 min at 70% heart 
rate reserve, 15 - 30 sec at 60% of maximal aerobic power and 60 – 90 sec at 70% of 
maximal aerobic power) up-regulated both phosphofructokinase and hexokinase 
activities, while CME (i.e. 30 – 45 min at 60 – 85% maximal heart rate reserve, 4 – 5 
sessions a week) down-regulated and induced greater enzymatic activities in both lipid 
oxidative and citric-acid cycle pathways than CME [97]. Furthermore, total energy 
expenditure was different between the two protocols (i.e. CME: 120.4MJ vs. AIT: 
57.9MJ) [97]. Difference in intramuscular adaptations between both HIIT and CME 
protocols, could be partly explained by the difference in substrate utilisation relative to 
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exercise intensity. Considering that exercising at a constant intensity of 6     O2max for 
30 min, would elicit maximal lipid oxidation rate, the glycolytic pathway may not be 
sufficiently stressed, therefore partly explaining the down-regulation of enzymatic 
activities in the glycolytic pathway observed after CME [140]. Comparison studies 
between SIT and CME reported similar increment in intramuscular metabolic capacity 
despite difference in total training volume [65, 141]. For instance, in a 6 week SIT 
versus CME comparison study, both training protocols induced similar increase in 
intramuscular glycolytic and lipid oxidative potentials, despite a substantial difference in 
total training volume (i.e. ~225kJ/week vs. ~2250kJ/week) [65]. Repeated sprints slowly 
increase energy derivation from the aerobic pathway, which likely explains the observed 
increase in both glycolytic and aerobic capacities [75, 142]. Therefore, both SIT and 
AIT are superior to CME in increasing intramuscular metabolic capacity, mediated by 
their ability to induce greater mitochondria biogenesis.  
2.6.2 Cardiovascular adaptations and improvements in hemodynamic parameters 
CME is commonly prescribed to improve aerobic fitness, however, in 
comparison to AIT; most comparison studies reported that the latter is superior to CME 
in eliciting greater improvement in aerobic capacity [32-34, 63, 64, 94]. Comparison 
studies using an isocaloric design between AIT and CME which reported greater 
improvement in aerobic fitness after AIT suggests that improvement in aerobic fitness is 
likely to be exercise intensity dependent [32-34, 64]. On the contrary, others have also 
reported similar improvements in aerobic capacity after both AIT and CME [108, 143]. 
For instance, Wisloff et al. (2007) reported that AIT (i.e. 4 min at 90 – 95% of HRpeak, 3 
min at 70% HRpeak, 3 sessions a week) elicited a greater improvement to   O2peak (i.e. 
AIT: 35% vs. CME: 16%) compared to CME (i.e. 47 min at 70 – 75% HRpeak, 3 sessions 
a week) [32]. However,  arburton et al. ( 004) observed that both AIT (i.e.   min at 
 0    O2peak, 2 min at 40    O2peak, 3 sessions a week) and CME (i.e.    below 
anaerobic threshold with progressive increment from 30 – 4  min, 3 sessions a week) 
elicited similar increment in   O2max [144]. It is likely that the disparity between both 
findings is a result of the different training protocols, and is plausible that the duration 
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spent exercising in the high-intensity is also crucial to the improvement in aerobic 
capacity.  
In addition to the improvement in calcium handling with enhance muscular 
contractility, AIT is also superior to CME in eliciting reverse left ventricle remodelling 
of the heart and improvement in endothelial function [32]. For instance, Wisloff et al. 
(2007) observed a decline in left ventricle systolic (i.e. by 15%), diastolic (i.e. 12%) 
diameters, a decline in pro-B-type natriuretic peptide level (i.e. marker of cardiac 
hypertrophy and severity of heart failure) by 40% and improvement in flow mediated 
dilation only after AIT and not CME [32]. Furthermore, the observed exercise intensity 
dependent balanced hypertrophy in cardiomyocytes in rats after AIT, supplements how 
AIT is superior to CME in enhancing cardiac function [138]. These studies indicate that 
AIT is likely to be superior to CME as an exercise intervention for cardiac rehabilitation. 
Pertaining to SIT and CME comparison studies, both protocols improved aerobic 
capacity [73, 110, 119], endothelial function [110] and peripheral artery distensibility 
[110] despite marked differences in exercise volume. For instance, despite difference in 
weekly workloads (i.e. AIT: 225 kJ vs. CME: 2250 kJ), both SIT and CME induced 
similar improvement in endothelial function and increment in distensibility in the 
popiliteal artery [110]. It is likely that the unique feature of work – rest intervals allows 
for prolonged training periods at or near maximal oxygen consumption, thereby also 
partly explaining the greater improvement in aerobic capacity after AIT and SIT [145, 
146]. However, despite AIT being superior over CME in eliciting greater improvements 
in vascular function, both AIT and CME have similar blood pressure lowering effect 
[33, 94]. For example, Tjønna et al. (2008) reported that AIT (i.e. 4 min at 90% heart 
frequency max, 3 min at 70% heart frequency max) and CME (i.e. 47 min at 70% heart 
frequency max) reduced systolic (i.e. by ~ 10 mmHg), diastolic (i.e. by  ~ 6 mmHg) and 
mean arterial (i.e. by  ~ 7 mmHg) blood pressures, although reduction of diastolic blood 
pressure in the CME group did not reach statistical significance [33]. Also, Schjerve et 
al. (2008) observed a decrement in diastolic blood pressure in both AIT (i.e. 4 min at 85 
– 95% HRmax, 3 min at 50 – 60% HRmax) and CME (i.e. 47 min at 60 – 70% HRmax) 
groups by  6 mmHg and 8 mmHg respectively, with no change in systolic blood pressure 
[94]. Similarly, 7 weeks of either SIT (i.e. progressive increment from 4 sets of 20 
 22 
maximal sprint running interspersed with 20 – 30 sec of active recovery, 3 sessions a 
week) or CME (i.e. 20 min of running at 70% VO2max) was reported to lower systolic 
blood pressure by ~ 5 mmHg in adolescents, although reduction in the CME did not 
reach statistical significance and there was no observable change in diastolic blood 
pressure in both protocols [119]. Therefore, extant studies demonstrated that AIT, SIT 
and CME can lower blood pressures however, reduction of blood pressure in CME 
usually does not reach statistical significance, hence comparison studies with greater 
statistical power may be needed to elucidate if CME in comparison to AIT and SIT can 
also significantly reduce blood pressure. 
2.6.3 Metabolic risk factors 
Besides cardiovascular parameters, 4 months of AIT (i.e. 4 min at 90% of HRmax, 
3 min at70% of HRmax, 3 sessions in a week) has been reported to be superior to CME 
(i.e. 47 min at 70% HRmax) in reducing overall metabolic risk factors (i.e. fasting 
glucose, HDL, triglycerides, body mass index, etc.), indicating that AIT is an effective 
intervention in reversing metabolic syndrome [33]. Furthermore, 3 - 4 months of AIT 
can attenuate lipogenesis in adipose tissue, while both AIT and CME are equal at 
reducing body weight and waist circumference [33, 94]. However, Tremblay et al. 
(1994) observed a more pronounced reduction in subcutaneous adiposity as assessed 
using skin fold measurements after AIT (i.e. 30 min at 70% heart rate reserve, 15 - 30 
sec at 60% of maximal aerobic power and 60 – 90 sec at 70% of maximal aerobic 
power) in comparison to CME (i.e. 30 – 45 min at 60 – 85% maximal heart rate reserve, 
4 – 5 sessions a week) [97]. Conversely, Nybo et al. (2010) observed that 3 months of 
AIT (i.e. 2 min at above 95% of HRmax, 1 min of passive rest, 2 sessions a week) was 
less effective than CME (60 min at 6     O2max, 2.5 times a week) in reducing overall 
body fat percentage when assessed using the DEXA [63]. Due to the difference in 
training protocols between studies, direct comparison cannot be made and may account 
for the difference in findings. Therefore, while AIT can attenuate lipogenesis in adipose 
tissue, its ability to reduce body weight and improve body composition may be similar 
or inferior to that of CME and more studies are needed to elucidate it further. In a 7 
week SIT (i.e. 20 m maximal sprints, 20 – 30 sec rest, 4 – 6 sets) and CME (i.e.  0 min 
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at  0    O2max) comparison study, while only BMI was improved after SIT, both BMI 
and body fat percentage were reduced after CME [119]. In another study, Macpherson, 
Hazell, Olver, Paterson and Lemon (2011) observed similar reduction in fat mass and 
increment in lean tissue mass after 6 weeks of either SIT (i.e. 30 sec maximal effort 
sprint, 4 min rest, 4 – 6 sets per session) or CME (i.e. 30 – 60 min at 6     O2max) in 
healthy individuals [73]. However, others have reported that 15 weeks of SIT is superior 
to CME in reducing both total body and fat masses and increasing trunk lean mass of 
sedentary but otherwise healthy women [111]. As such, it is likely that 6 – 7 weeks of 
SIT can elicit improvement to BMI and body composition, equal that observed after a 
similar period of CME. While, it is likely that SIT is superior to CME over longer 
training period of up to 15 weeks, more studies over the similar time frame are needed to 
substantiate it further.  
In comparison with CME, 3 months of AIT is observed to have similar effect 
with reducing blood glucose during OGTT in healthy individuals while in one other 
study [63], 4 months of AIT had a greater effect in reducing fasting blood glucose levels, 
resulting in an improvement in both insulin sensitivity and beta-cell function using the 
HOMA model in those with metabolic syndrome [33]. In a comparison study between 
SIT and CME in adolescents over 7 weeks, authors observed that only CME marked 
reduced fasting insulin levels [119]. However, Trapp et al. (2008) reported that after 15 
weeks of exercise intervention, only the SIT (i.e. progressive increment of 8 sec 
sprinting against 0.5kg followed by 12 sec of slow cycling over 15 weeks) group had a 
significant decrease in fasting insulin levels from the control group. These observations 
suggest AIT is superior if not similar to CME in improving glucose homeostasis. Few 
studies have compared the effect which both CME and SIT have on glucose and insulin 
homeostasis, the findings are equivocal, therefore further SIT and CME comparison 
studies are needed to investigate this further.  
Finally, 4 months of AIT and CME did not elicit any changes in lipid profile (i.e. 
triglycerides, total cholesterol and LDL) [33]. Similarly, in a study by Buchan et al. 
(2011), both SIT and CME did not elicit any changes in HDL, LDL and total cholesterol 
levels but elicited an increase in triglycerides level in adolescents [119]. The present of 
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elevated triglycerides level is uncommon, however considering that physiological 
responses to exercise may differ between adults and adolescents, this may be an isolated 
effect in adolescents. [147]. There are limited studies comparing the effects of both AIT 
and SIT with CME on lipid profile, however present studies show that in comparison to 
CME, both SIT and AIT elicit negligible changes to lipid profile, therefore more studies 
are warranted.  
In summary, both AIT and SIT are superior to CME in eliciting increment in 
both intramuscular glycolytic and oxidative capacities, despite marked difference in 
energy expenditure and time commitment. These enhancements can be attributed to the 
greater exercise intensity exposed during AIT and SIT. Furthermore, AIT is superior to 
CME in reducing overall metabolic risk factors. In fact, studies have demonstrated that 
both AIT and SIT have similar blood pressure lowering effect to CME. However, 
compared to CME, both AIT and SIT have divergent results on promoting weight loss 
and improvement to body composition. AIT seems to have similar if not inferior effects 
in these aspects as compared to CME while SIT is inferior to CME. In regards to glucose 
homeostasis, the literature indicates that AIT is superior to CME in maintaining fasting 
glucose levels and improving basal insulin sensitivity and beta-cell function. In addition, 
it is inconclusive if SIT is superior to CME in improving fasting plasma insulin levels or 
insulin sensitivity, since findings are equivocal; therefore more research is needed to 
ascertain it. Importantly, although isocaloric studies comparing between AIT and CME 
reported similar adaptations or improvements to health markers in both protocols, it 
must be highlighted that these favourable changes occurred over shorter exercise 
duration, meaning lower time commitment in the AIT protocols. These studies including 
those studies comparing between SIT and CME, underscores the time efficient quality of 
HIIT and that improvement to health, exercise tolerance and capacity can occur over 
shorter time using HIIT, as opposed to engaging in CME.  
2.7 Gaps in the research 
In the previous sections, we have discussed about the intramuscular adaptations 
and health benefits observed after both short and long term HIIT. Furthermore, we also 
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examined these observations in relation to the conventional continuous moderate-
intensity exercise in an attempt to determine its efficacy as a potential alternative 
exercise modal. However as mentioned previously, there are still gaps in the literature 
which call for more research before we can recommend its prescription to the general 
public. This study is designed to address some of these gaps and they will be discussed 
in the following sections. 
2.7.1 Comparison of acute responses to a single high-intensity interval session 
versus a single continuous moderate-intensity session  
Long term study of training adaptations and the resulting health improvements 
from long term adherence to an exercise intervention is important to establish its long 
term efficacy. However, the study of acute responses to a particular exercise intervention 
is just as important. These acute responses or termed “last exercise bout” effects can be 
defined as the immediate and transient physiological responses elicited by a single bout 
of exercise, which can occur during or over a short period of time after exercise and can 
have major positive health related implications [37].  urthermore, “last exercise bout” 
effects can confound results in long term training studies, making it difficult to 
distinguish them from training adaptations [148]. 
Research on acute responses to a single session of SI is scarce. A single SI 
session consisting of 4 sets of 30 seconds “all-out” sprints against 0.0  kp kg interposed 
with 4 min of active recovery with or without replacement of the energy deficit from the 
session has been reported to significantly reduce plasma level of triglycerides but not 
insulin and glucose levels in response to a high fat meal 24 h after the session; 
furthermore, fasting plasma triglycerides, insulin, glucose and NEFA levels were not 
affected [149]. Consistently, others have reported that a single bout of SI did not affect 
plasma glucose, insulin and NEFA levels between 12 h to 72 h post exercise [129, 150]. 
In comparison between a single  I (i.e.        O2peak for 30 seconds interposed with   
min of rest) versus CME (i.e.       O2peak for 15 min interposed with 2 min of rest) 
session, only the CME resulted in significant improvement to both fasting and OGTT 
insulin sensitivity indices, possibly resulting from the observed lower fasting and OGTT 
at 60 min insulin levels [150]. However it must be highlighted that long term SIT can 
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improve insulin sensitivity as mentioned previously [1, 128, 129].  In adolescents, a 
single  I session consisting of   sets of 30 seconds “all-out” sprints against  .   of their 
body mass, interposed with 4 min of passive recovery can significantly reduce systolic 
blood pressure 90 min post-exercise and also increase resting energy expenditure over 
30 min post exercise [151]. The health implication of “last exercise bout” effect can be 
illustrated using this finding, for example, we can posit that this protocol can be utilised 
by adolescents with pre-hypertension in accumulative daily 9 min bouts to regulate their 
daily average blood pressure. 
The implication of the “last exercise bout” effects on confounding “actual” 
training adaptations can be illustrated in the following example. In a 2-week SIT 
intervention on overweight/obese sedentary individuals by Whyte, Gill and Cathcart 
(2010), they reported transient decrease in plasma insulin levels under glucose loading, 
resting energy expenditure, carbohydrate oxidation rate and systolic blood pressure, 
increase in lipid oxidation rate and improvement in insulin sensitivity, all of which were 
no longer significant against baseline levels at 72 h post intervention [1]. The authors 
postulated that such a finding could be due to the acute response from the last training 
bout [1]. Furthermore, specific to insulin sensitivity, Richards et al. (2010) measured 
change in insulin sensitivity 72 h after a single SI session, reported no significant 
difference [129]. Therefore, it is possible that the significant improvement in insulin 
sensitivity observed by Whyte et al. (2010) is an acute response to the last exercise bout. 
Kessler, Sisson and Short (2012), emphasised the importance of defining the timing of 
post training tests to avoid confounding adaptive effects from exercise training with “last 
exercise bout” effects [70].  
In a recently published study, Bartlett et al. ( 0  ) reported that both a single 
aerobic interval (AI) session involving 6 sets of 3 min work to rest ratio using workloads 
corresponding to  0    O2max for work and  0    O2max for rest intervals and single 
CME session of cycling for  0 min at a workload corresponding to  0    O2max, when 
matched for average intensity, workload and duration, induced similar level of 
phosphorylation of the intracellular signalling pathways that elicit mitochondria 
biogenesis and consequentially matched level of PGC- α mRNA 3 hours post exercise 
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[152]. However, long term comparison studies have observed that long term AIT 
induced a greater increase in PGC- α protein content than CME [33, 94]. Despite this 
disparity, direct comparison cannot be made due to differences in the study designs, such 
as a longer work interval (i.e. 3 vs. 4 min) and the lack of control for both exercise 
duration and mean intensity in the long term studies. In fact, having a longer work 
interval means that the mean intensity for the AIT protocol in both the long term studies 
was greater than the CME protocol (i.e. ~80% vs. 70% of HRmax or heart frequency 
max) while in the Bartlett et al. ( 0  ), mean intensity ( 0  of   O2max) was similar 
between protocols. Since transcription of PGC- α mRNA is likely to be exercise-
intensity dependent and influenced by the increasing muscle fibres recruitment relative 
to exercise intensity limited at maximal exercise intensity, this could be a plausible 
explanation as to why Bartlett et al. (2012) did not find any difference in PGC- α 
mRNA content between both protocols while the long term comparison studies did [139, 
153, 154]. In addition, Bartlett et al. (2012) also noted that elevation in plasma levels of 
both glycerol and NEFA were significantly greater 3 hours after CME and attributed this 
finding to lactate-induced inhibition of lipolysis, which levels were more elevated during 
the AI, possibly due to differential muscle fibres recruitment (i.e. both type I and II 
fibres during AI) [152]. The difference in substrate appearance is consistent with 
previous findings that low – moderate intensities resulted in greater rate of appearance 
(Ra) of free fatty acids (FFA) with the Ra attenuating with increasing exercise intensity 
[155]. Interestingly, while increasing exercise intensity can enhance lipid oxidation and 
increase energy expenditure for over 90 min post exercise, an interval cycling session 
utilising 1:2, work to recovery ratio at 85% VO2max for work and 30% VO2max for 
recovery, in comparison with moderate-intensity cycling at 50% VO2max, with both 
protocols matched for mean exercise intensity, duration and total energy expenditure did 
not result in any significant difference in energy expenditure, RER kinetics or lipid 
oxidation rate over 90 min post exercise [74]. In addition, a single bout of CME can 
reduce 24 h systolic, diastolic blood pressures, night time systolic and diastolic blood 
pressures, while a single bout of AI can reduce 24 h systolic blood pressure and night 
time systolic blood pressure in medically treated hypertensive patients [156]. From this, 
it is clear that CME is superior to AI in eliciting favourable acute hemodynamic 
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responses however it also highlights that AI can be also used as an intervention to 
mitigate hypertension blood pressure.  
In summary, research on the “last exercise bout” effects from HIIT modalities is 
scant. Considering that AIT in comparison to SIT, is more widely prescribed to both the 
general and especially the clinical populations, the need for more research into these 
acute responses to a single AI session is twofold: it provides exercise physiologists with 
greater understanding so as to improve the prescription of AI as both prophylactic and 
auxiliary treatment for lifestyle-related chronic diseases and allows for better 
discrimination against “true” training adaptations against “last exercise bout” effects. At 
present, the literature has provided some insights on the acute responses to a single AI 
session: it activates intramuscular signalling pathways that promote mitochondrial 
biogenesis, attenuate appearance of glycerol and NEFA, enhance lipid oxidation rate and 
lower RER kinetics for up to 90 min post exercise and in hypertensive patients it 
improves 24 h average blood pressure. However, an interesting perspective observed is 
that when all three exercise variables, namely mean exercise intensity, duration and 
expenditure are controlled for, the acute intramuscular responses and post exercise 
metabolism after either a single AI or CME session are both similar. Notably, more 
research is needed to provide for a more comprehensive understanding of “last exercise 
bout effects” after an AI session on other metabolic and health markers such as insulin 
sensitivity, central hemodynamic parameters and cortisol responses. Furthermore, the 
extent of the duration of the effects if any at all, measured over 72 h after the AI session 
to allow future long term intervention studies to discriminate between “true” training 
adaptations from “last exercise bout” effects. 
2.7.2 Comparison of acute cortisol response immediately after a single session of 
AI versus CME 
Glucocorticoids, especially cortisol are part of the endocrine system adaptive 
response towards physiological and mental stress such as exercise or pre-competition 
anxiety [38]. In fact, literature suggests that cortisol may be responsible for several 
observed metabolic and physiological adaptations such as mitochondria biogenesis, 
improvement in beta-cell function and its proliferation resulting from exposure to stress 
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(i.e. exercise) and exercise induced enhance lipolytic action in adipose tissue  [41, 157, 
158]. During exercise, the stimulation of the hypothalamus-pituitary-adrenal, resulting in 
the secretion of glucocorticoids, plays an essential role in mobilising substrates for the 
increase metabolic demands [39, 159]. It is clear when individuals are placed under both 
emotional and physiological stress which can be elicited simultaneously through 
exercise, cortisol levels are raised, as seen during and after either exhaustive cycling at 
  6  of   O2max or prolonged cycling (i.e. 50 min) at anaerobic threshold with the latter 
having a more pronounced effect [160]. Therefore, both exercise duration and intensity 
mediate the secretion of glucocorticoids during and after exercise. Indeed when 
exercising at     of   O2max, a sustained duration of at least 80 min is required to elicit 
an elevation in cortisol levels during exercise [161]. Others have reported that a duration 
threshold of more than 40 min and high-intensity exercise at  6  of   O2peak is required 
to observe an elevation in cortisol levels during exercise [42]. Consistently, not only did 
60 min of cycling at  0  of   O2max not elicit an increase in cortisol levels but further 
decreased it, however 4 sets of 30 seconds “all-out” supramaximal cycling bouts 
separated by 5 min of rest after each set elicited an increase in cortisol levels at 10 and 
60 min post-exercise [44].  eparately, after a single 30 seconds “all-out” supramaximal 
cycling bout, cortisol levels were observed to be significantly higher than pre-exercise 
levels at  0 min post exercise, while cortisol levels were significantly increased 
immediately after 30 min of cycling at  0  of  O2max [43]. Taken together, we can infer 
that at low intensity (i.e.      of   O2max), exercise duration needs to be longer than  0 
min to elicit an increase in cortisol levels, however with increasing exercise intensity 
(i.e. ≥ 0  of  O2max), this exercise duration threshold becomes shorter (i.e. ≥30 min).  
Therefore, the observation of cortisol levels after an acute bout of exercise 
provides information on the extent of physiological stress induced by that particular 
exercise protocol. It is consistent from the extant studies on healthy young males in the 
literature that a delayed spike in cortisol levels occurring 10 – 20 min can be observed 
after a SI protocol [43, 44]. Furthermore, while cortisol responses after a CME protocol 
involving cycling at  0  of   O2max for 30 min is similar to a single sprint, cycling at 
 0  of   O2max for 1 hour is unable to elicit greater post exercise cortisol levels in 
comparison to after a SI session consisting of 4 maximal “all-out sprints” interposed 
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with 5 min of passive rest [44]. Unlike the SIT, the influence of a single AI on cortisol 
response has not been extensively studied. Furthermore, cortisol response towards 
exercise stress in obese individuals has been shown to be different to lean individuals, 
usually more pronounced [45]. In fact, overweight and obese individuals have been 
characterised with elevated basal cortisol than their lean counterparts [45, 162], 
however, it can also be lower than their counterparts as observed by others [163]. 
However, study has shown that 12 weeks of moderate intensity exercise (i.e. 60 – 65% 
HRR) reduced cortisol levels [164]. In fact, it has been shown that multiple bouts of high 
intensity interval exercise (i.e. 4 – 5 sets of 2 min at 100 – 110% of   O2max,   min at 
40    O2max) during the day resulted in lower night cortisol levels than multiple bouts of 
continuous moderate-intensity exercise (i.e. 4  min and 60 min at 6   of  O2max) [165]. 
Accordingly, it is likely AIT which can be greater in exercise intensity may be used to 
reduce elevated cortisol levels found in obese individuals. Therefore, in consideration 
that AIT is commonly advocated for both the general and clinical populations as it is 
better tolerated in comparison to SIT and that overweight and obese individuals who 
tend to be physically inactive and are at risk of developing metabolic diseases would be 
likely candidates for exercise prescription, more research is required to understand the 
cortisol response in these individuals elicited after a single AI session. 
 2.7.3 Comparison of exercise preference between HIIT versus CME 
HIIT is a time efficient exercise modality with the potential to be an alternative 
against the traditionally recommended CME. As mentioned previously, “lack of time” 
has been consistently proposed as a barrier against the engagement of physical activity 
and while HIIT can circumvent it, there are other barriers to be considered. Both 
perceived enjoyment of physical activity and physical activity preference are factors 
which have been frequently reported to influence physical activity participation and 
adherence [20, 166, 167]. Taken together, it is imperative that for any exercise modality 
to be successfully introduced to the general population, it has to be able to overcome 
these barriers. Drawing insights from the literature, HIIT may receive less aversion as 
compared to other forms of long-period type vigorous intensity activities, since the 
interposed low-intensity active or passive recovery bouts may attenuate the 
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unpleasantness from each high-intensity bouts [168]. At present, not much research has 
been done towards determining whether HIIT may be perceived as an enjoyable exercise 
intervention while extant reports are mostly anecdotal evidence.   For example, in a 
previously mentioned SIT study, Richards et al. (2010) evaluated that compliance rate 
for the study was high due to two contributing factors, mainly the substantial verbal 
encouragement given and supervision during every training session [129]. In an AIT 
intervention study on patients with metabolic syndrome, Tjønna et al. (2008) reported 
informal comments that participants performing AIT found the varying intensity to be 
motivating while those performing CME found it “quite boring” to walk continuously 
[33]. A study by Bartlett et al. (2011) comparing the perceived enjoyment of performing 
either high-intensity interval (i.e. 3 min at  0    O2max, 3 min at  0    O2max) or 
continuous moderate-intensity (i.e.  0 min at  0    O2max) running using a previously 
validated “Physical Activity Enjoyment  cale” reported that recreationally active men 
experienced greater enjoyment performing the former to the latter [2]. However, one 
must be cautioned against applying this finding to other populations such as those who 
are morbidly overweight or obese. For example, Sim et al. (2014) found that overweight 
individuals perceived similar enjoyment from both AI (i.e.   min at  00    O2peak, 4 min 
at  0    O2peak) and CME (60    O2peak). This disparity in reported perceived 
enjoyment between recreationally active and overweight individuals suggests that 
perception of enjoyment from AIT cannot be generalised between both cohorts. Studies 
have indicated overweight individuals find physical activity less pleasurable and their 
level of enjoyment can be further diminished if exercise intensity is above which that 
they prefer [47]. Therefore, it is imperative that research be invested into determining 
the optimal AIT protocol such that perceived enjoyment is not compromised for these at 
risk individuals.  
2.7.4 Conclusion: Addressing the gaps 
Physical activity is a modifiable risk factor for obesity and its accompanying co-
morbidities. It also augments other risk factors which are consequences of unfavourable 
metabolic changes from adopting a sedentary lifestyle. The clustering of these risk 
factors is associated with the term “metabolic syndrome”. Recently, HIIT has been 
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proposed as an alternative exercise modality to the conventional CME. The work to rest 
intervals, a hallmark feature of HIIT forms the premise for its use in individuals with 
reduced capacity to exercise since it allows sustained exposure to increase cellular stress, 
thereby allowing greater physiological adaptations which otherwise would require 
greater volume and duration for the similar effect to be achieved in convention CME. 
Importantly, both AIT and SIT have been safely prescribed to various clinical 
populations despite the increased risk of cardiovascular accident that accompanies the 
participation of vigorous physical activity. In fact among the different HIIT protocols, 
reviews in the literature advocates the prescription of AIT to both the general and 
especially clinical populations. However, there are several gaps pertaining to AIT which 
need to be addressed. There is an exigency for studies to look at the acute physiological 
effects from a single AI session to allow for better understanding and discrimination 
between the “last exercise bout effects” versus training adaptations.  urthermore, 
comparison between a single AI and CME session is required to highlight the difference, 
if any on the acute physiological effects on health and metabolic markers, especially 
since single bout of exercise accumulated over several sessions is just as important as 
long term adherence to an exercise programme on health. In addition, the observation of 
cortisol response can provide an illustration of the extent of physiological and emotional 
stress elicited by an exercise protocol. In fact, the literature indicates that both exercise 
intensity and duration play important role in mediating cortisol response during and after 
an exercise bout. Extant studies have examined and compared the effects from a single 
SI session and CME session on cortisol response; however, the influence from a single 
AI session and in comparison to a single CME session on cortisol response has not been 
examined. Further to that, the acute cortisol responses elicited by overweight or obese 
individuals after a single AI session has not been examined, which is important since 
this population group is at risk of developing metabolic diseases and thus are prime 
targets for exercise prescription. Lastly, both exercise intensity and exercise preference 
play important roles in determining exercise adherence. For overweight or obese 
individuals, the prescription of a pre-determined exercise intensity that is above their 
preferred exercise intensity threshold can have negatively affect exercise preference and 
consequentially reduce exercise adherence. Overweight and obese individuals are prime 
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targets for exercise prescription as prophylactic measure against metabolic diseases 
since they are usually physically inactive, however AIT involves brief escalation into 
high exercise intensities and therefore may affect exercise preference, thus exercise 
preference for AIT needs to be examined in this particular group of individuals and 
comparison to be made against CME to determine which exercise modality is more 
preferred.  
In conclusion, we can confidently prescribe AIT to both the general and clinical 
populations; some of these gaps need to be addressed. By closing these gaps, there can 
be positive implications for both the research and clinical communities.  
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CHAPTER THREE METHODS 
3.1 Subjects 
Twelve overweight/obese sedentary males were recruited to participate in this 
study, however, four dropped out for personal reasons (n = 8). Participants were 
recruited on the basis that they were sedentary (i.e. engaging in less than 1 h/week of 
structured exercise), aged between 19 to 55 years and had a BMI greater than 25 kg/m
2
. 
Each participant readiness to participate in physical activity was assessed using the 
“Physical Activity Readiness Questionnaire” (PAR-Q), created by the Canadian Society 
for Exercise Physiology [169]. Participants who answered positively to any questions in 
the PAR-Q were required to fill out a medical questionnaire and obtain medical 
clearance from a medical practitioner before inclusion into the study. Participants were 
excluded if they were smokers, currently taking medications that could confound the 
results of the study and were unable to receive medical clearance from a medical 
practitioner. The study protocol and procedures were approved by Edith Cowan 
University’s human research ethics committee. Participants provided written informed 
consent prior to participation in the study. Throughout the study, participants were 
requested to maintain their sedentary lifestyle and to refrain from participating in any 
strenuous physical activity.  Furthermore, participants were asked to avoid the 
consumption of caffeinated and alcoholic beverages 6 h prior to all trials.  
3.2 Study design 
Participants attended the laboratory on 11 separate occasions to perform, two 
maximal aerobic capacity tests, two exercise trials and seven measurement sessions 
(Figure 1). On the first and second visits, participants performed two incremental 
exercise tests to exhaustion, interposed by 2 days for determination of their peak aerobic 
capacity. On the third visit, anthropometric and baseline measurements were assessed 
(described below) and dietary intake 24 h prior was recorded by participants and 
replicated in the subsequent measurement sessions. In a randomised and 
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counterbalanced order, participants then performed two exercise trials with a seven days 
washout period interposed between each trial. These exercise trials involved an AI 
session and a CME session (described below). After the completion of each exercise 
trial, participants completed a “Physical Activity Enjoyment  cale (PACE )” 
questionnaire, to evaluate their perceived level of enjoyment of the exercise trial. The 
PACES is a valid [170] 18-item questionnaire with each item having a 7-point scale (see 
appendix 2). Saliva samples were also collected prior to, at 10 and 30 min post exercise 
trial. At 24 h, 48 h and 72 h following each trial, participants returned to the laboratory 
for measurements which were similar to that performed at baseline (described below). 
Anthropometric measurements (only DEXA assessments) were taken again at post 72 h 
of the last exercise trial. 
 
Figure 1. Schematic illustration of the study design. 
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3.2.1 Incremental exercise test 
Participants performed the incremental cycling tests on an electronically braked 
cycle ergometer (Velotron Pro, RacerMate, Seattle, WA). Each participant performed 
the test twice and the highest power output elicited between both tests was used to 
determine the workloads for both exercise trials (described below). The test commenced 
at a workload of 30 W which gradually increased by 3 W every 12 s (i.e. 15 W every 
min). Participants continued cycling against the increasing workload until either 
volitional exhaustion or a cadence greater than 50 rpm could no longer be maintained. 
Verbal encouragement was given throughout the protocol. Gas exchange was assessed 
throughout the test using a TrueOne® gas analyser (Parvo Medics, Sandy, Utah USA) 
which was previously verified [171]. Before all testing sessions, the gas analyser was 
calibrated using alpha gases of known concentration and the volume transducer was 
calibrated using a 3   syringe (Hans Rudolph,  ansas, MO).   O2peak was established as 
the highest   O2 value recorded over    s average. The peak power output (PPO) was 
defined as the workload corresponding   O2peak. Heart rate (HR) (Polar S610, Polar, 
 inland) and rating of whole body perceived exertion (RPE) (Borg’s RPE scale, 6 - 20) 
were recorded at 2 min intervals during the test.  
3.2.2 Exercise trials 
Participants performed the two exercise trials on the Velotron cycle ergometer. 
Both were designed to match for trial duration (CME: 40 vs. AI: 42 min) and total work 
(CME: 256.5 ± 42.6 vs. AI: 253.3 ± 42.1 kJ), while allowing differences in exercise 
intensity between trials. Briefly, in the CME bout; participants cycled for 40 min at 50% 
of their individual PPO, determined during the incremental exercise test. The intensity 
and duration for this trial was based on previous research and chosen to mirror the 
minimum intensity and duration of conventional exercise prescription guidelines [74]. 
During the AI bout, participants completed a total of 13 interval repetitions of 1 min at 
85% of their individual PPO. Each repetition was interposed with 2 min of low intensity 
cycling at 30% of their individual PPO. Prior to the high-intensity efforts participants 
performed a 3 min warm up at 30% of their individual PPO. The total exercise time for 
this trial was 42 min. 
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Total work performed during each trial was calculated based upon the following 
formula:  
               
Where P is the power output calculated from the percentage of the PPO (W) and 
t (min) is the total time during which the power output was elicited. Total energy 
expenditure for the high-intensity bout included the warm-up.  
Throughout both exercise trials, HR (Polar S610, Polar, Finland) and RPE 
(Borg’s RPE scale, 6-20) were recorded at rest, 4 min and every 6 min thereafter (i.e. the 
end of every second interval). Throughout both trials, participants were provided with 
continuous feedback on time and their power output. Participants were also allowed to 
consume water ad libitum. 
3.2.3 Measurements 
 
 3.2.3.1 Blood sampling and analysis 
Venous blood samples were collected by certified phlebotomist at a commercial 
pathology laboratory following a 12 h fast. Fasting blood samples were collected 
between 8:00am and 10:00am. During blood sampling, blood was drawn into fluoride 
oxalate and serum separator vacutainers (Vacutainer; BD, Oxford, United Kingdom). 
Serum separating tubes were left to clot for 30 min at room temperature. All samples 
were centrifuged at 3000 rev/min for 10 min at ambient temperature. Plasma and serum 
samples were immediately analysed for glucose, triglycerides and cholesterol, while 
additional serum samples were frozen at -80°C and later analysed for insulin. 
Commercially available kits were used for the analysis for triglycerides, total cholesterol 
and HDL (ADVIA Chemistry; Siemens, Munich, Germany) on an automatic analyser 
(ADVIA Chemistry 2400; Siemens, Munich, Germany). LDL was estimated from 
measured triglycerides and total cholesterol levels using the Friedewald equation, 
however where triglycerides are > 4.5 mmol/L, derived values are unreliable and 
therefore were omitted as was for one participant [172]. Insulin was determined using an 
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enzyme-linked immunoassay (EIA) (Immulite® 2000 Insulin, Siemens, Munich, 
Germany) on an automatic analyser (Immulite XPI, Siemens, Munich, Germany). 
Insulin values below the instrument limits of detection were reported as the lowest 
possible level of detection (2 mU/L). All analyses for each sample were performed in 
duplicate. 
3.2.3.2 Saliva collection and analysis 
 
 Participants did not have any dental surgery or wearing gum shields 48 hrs prior 
to saliva collection and refrained from brushing or flossing their teeth, 45 min prior to 
their arrival at the exercise laboratory [173-175]. There were no oral lesions present 
during the time of testing [173]. At least 10 min before sampling, participants rinsed 
their mouth with water and swallowed the first pool of accumulated saliva [173]. The 
passive drool method was utilised to collect unstimulated saliva, which involved 
directing pooled saliva through a polypropylene drinking straw into 2 mL cryovials 
(Salimetrics, State College, PA, USA) by getting participants to tilt their head slightly 
forward with eye open while making minimal orofacial movement [176]. Collected 
saliva samples were immediately stored at -80°C until further analysis [173-177]. 
Salivary cortisol was analysed using commercially available EIA kits (Salimetrics, State 
College, PA, USA).  
 3.2.3.3 Insulin resistance  
Insulin resistance (IR) was estimated using the HOMA2-IR. Assuming healthy 
normal-weight subjects who are  3  years old, with  00  β-cell function and an insulin-
resistance of  , approximation of the insulin resistance and β-cell function in a patient can be 
calculated using the plasma concentration of both glucose and insulin at fasting basal level 
using the following formulas [178]: 
        
                 
    
 
The model has been previously validated against euglycaemic hyperinsulinaemic 
clamp protocol and has been shown to correlate with insulin sensitivity in both healthy 
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(RS=0.83, p<0.01) and diabetic individuals (RS=0.92, p<0.01) [178]. Similarly, the HOMA-
IR index also correlates well with the euglycaemic hyperinsulinaemic clamp protocol in 
obese and older (i.e. 57 years old) individuals [179]. The coefficient of variation for HOMA-
IR function has previously been reported to be 34% [178]. The HOMA2 model provides 
non-linear solutions, accounts for variations in hepatic and peripheral glucose resistance, 
with the insulin secretion curve modified to allow for an increase in insulin secretion in 
response to a plasma glucose concentration of >10 mmol/L and allows for use with newer 
assays [180]. 
 3.2.3.4 Anthropometric assessment 
Both body mass (measured to the nearest 0.01 kg) and height (measured to the 
nearest 1.0 cm) were measured using an electronic scale and stadiometer (seca763, seca, 
Germany). Waist circumference was measured in a horizontal plane, midway between 
the inferior margin of the ribs and the superior border of the iliac crest [127]. Waist 
circumference was measured to the nearest 1.0 cm. Body fat percentage, lean tissue 
mass and body fat mass were determined from a whole body scan using dual-energy X-
Ray absorptiometry (DEXA) (Hologic Discovery A, Waltham, MA). 
 3.2.3.5 Resting metabolism and substrate utilisation 
Participants rested in a supine position on a bed, in a private and dimly 
illuminated room with temperature maintained between 22°C to 25°C for 10 min. 
Thereafter, pulmonary gas exchange was continuously measured and averaged each min 
over 20 to 40 min using a TrueOne® gas analyser (Parvo Medics, Sandy, Utah USA) [1, 
181]. A 5 min steady state interval was used for the determination of energy 
expenditure. Only data with respiratory quotient within the physiological range of 0.67 
to 1.3 was used [182]. Heart rate was measured simultaneously using telemetry (Polar 
S610, Polar, Finland). Resting metabolic rate (RMR), estimated resting energy 
expenditure (REE), CHO oxidation rate (MCHO) and lipid oxidation rate (Mlipid) were 
derived from the following equations [181-184]: 
RMR (kcal/min) = (3.941 x VO2) + (1.106 x VCO2) – (2.17 x uN2) 
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REE (kcal/day) = RMR x 1440 min/day 
MCHO = (4.55 x VCO2) – (3.21 x VO2) – (2.87 x uN2) 
MLipid = (1.67 x VO2) – (1.67 x VCO2) – (1.92 x uN2) 
Urinary nitrogen (uN2) was assumed to be 0.11 mg/kg/min for all metabolic 
calculations, with reference to previous studies [183, 185]. 
3.2.3.6 Resting hemodynamic parameters  
Following the resting energy expenditure measurement, blood pressure (BP) was 
measured while participants were still in a supine position. Blood pressure was measured 
using a cuff sphygmomanometer (Medical Industries Australia, Land Cove, NSW) twice 
on the right arm with a 5 min interval between assessments, during which pulse wave 
analysis was performed [186]. Pulse wave analysis was performed using a 
sphygmocardiogram (SphygmoCor; AtCor Medical, Sydney) and involved the 
derivation of the central aortic BP through the non-invasive reconstruction of the aortic 
pulse wave from the radial pulse wave. The radial pulse wave was recorded using a 
handheld high fidelity tonometer (SPT-301B; Millar Instruments, Houston, TX) placed 
on the surface of the skin superficial to the radial artery with the application of a light 
pressure to applanate the radial artery against the radius bone [187, 188]. Both brachial 
BP measurement and pulse wave analysis were performed twice and the average was 
reported. The indices generated from the estimated central aortic pulse wave provide an 
illustration of the hemodynamics between the ventricle-vascular interaction [187]. 
Briefly, the central augmentation index is adjusted to a HR of 75 beats per min (bpm) 
(Alx@HR75) is calculated as the difference between the area under the late systolic 
peak and early systolic peak of the aortic pulse wave as a percentage of the pulse 
pressure [186]. The subendocardial viability ratio (SEVR) is defined as the percentage of 
the ratio between the area under during diastole and systole [187]. Derived aortic 
pressure and augmentation index using SphygmoCor has been previously validated 
[189-192] and measurements have been shown to be highly reproducible [188, 193, 
194].  
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3.3 Statistical analysis 
Statistical analysis was performed using the Predictive Analytic Software (PASW) 
version 19 (Chicago, IL, USA). All results are presented as mean ± standard deviation (SD), 
unless otherwise stated. Significant differences between exercise trials (CME and AI) and 
over time were assessed using a two-way repeated measures analysis of variance (ANOVA). 
 here significance between main effects interaction were identified, the  isher’s   D post-
hoc test was performed.  A dependent student’s t-test was used to assess for significance in 
the PACES scores and total work performed between exercise trials. Significance was 
defined as p < 0.05 for all analyses.  
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CHAPTER FOUR RESULTS 
4.1 Exercise responses during trials 
The demographics for the 8 overweight/obese participants are presented in Table 
1. There was a significant difference in the total work performed between exercise trial 
(CME: 256.5 ± 42.6 vs. AI: 253.3 ± 42.1 kJ, p < 0.05), however, the difference is 3.2 ± 
0.5 kJ. The RPE was only higher in the AI trial, compared with the CME trial, only at 
the 28 min time point (p < 0.05) (Figure 2A). The HR response to exercise was higher 
during the AI trial, compared with the CME trial (p < 0.05) (Figure 2B). 
Table 1.  Demographics of participants (n = 8)  
 Baseline Post study 
 
 
 
Mean ± SD Mean ± SD 
Age (y) 
 
37 ± 12 - 
Height (cm) 
 
174 ± 6 - 
Weight (kg) 
 
94 ± 12 - 
BMI (kg/m
2
) 
 
31 ± 3 - 
Waist circumference (cm) 
 
103 ± 10 - 
Hip circumference (cm) 
 
105 ± 6 - 
Waist-hip ratio 0.99 ± 0.06 - 
Lean tissue mass (kg) 65 ± 8 65 ± 8 
Fat mass (kg) 27 ± 6 27 ± 6 
Fat-free mass (kg) 68 ± 8 67 ± 8 
Bone mineral content (g) 2.66 ± 0.46 2.65 ± 0.46 
Body fat percentage (%) 28 ± 4 28 ± 4 
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Figure 2. Whole body rating of perceived exertion (RPE; A) and heart rate (HR; B) measured during bouts of continuous 
moderate-intensity (CME) and aerobic interval (AI) exercise. * denotes significant difference (p < 0.05) between trials. 
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  CME AI 
 
Baseline 24 h post 48 h post 72 h post 24 h post 48 h post 72 h post 
Blood metabolites 
and insulin 
       
Fasting plasma 
glucose (mmol/L) 
5.36 ± 0.75 5.26 ± 0.54 5.29 ± 0.53 5.56 ± 0.72 5.33 ± 0.54 5.40 ± 0.60 5.34 ± 0.57 
Fasting plasma 
insulin (mU/L) 
10.13 ± 6.53 9.75 ± 6.56 7.63 ± 5.18 9.88 ± 8.44 8.88 ± 6.10 10.00 ± 5.71 9.38 ± 5.24 
Fasting plasma 
triglycerides 
(mmol/L) (n = 7) 
1.87 ± 0.91 1.91 ± 1.03 1.66 ± 0.93 1.71 ± 0.93 1.76 ± 0.75 1.51 ± 0.72 1.60 ± 0.75 
Fasting plasma 
total cholesterol 
(mmol/L) 
5.09 ± 0.92 5.31 ± 1.24 5.24 ± 1.03 5.25 ± 1.04 5.16 ± 0.93 5.11 ± 1.04 5.34 ± 1.03 
Fasting plasma 
HDL (mmol/L) 
1.25 ± 0.64 1.43 ± 0.71 1.33 ± 0.64 1.16 ± 0.26 1.14 ± 0.28 1.18 ± 0.29 1.16 ± 0.28 
Fasting plasma 
LDL (mmol/L)  
(n = 7) 
3.21 ± 0.84 3.36 ± 1.19 3.39 ± 1.02 3.33 ± 0.90 3.19 ± 0.81 3.26 ± 1.09 3.46 ± 1.02 
HOMA2-IR 1.3 ± 0.9 1.3 ± 0.8 1.0 ± 0.7 1.3 ± 1.1 1.2 ± 0.8 1.3 ± 0.7 1.2 ± 0.7 
Hemodynamic 
parameters 
       
Brachial systolic 
pressure (mmHg) 
133 ± 17 132 ± 19 131 ± 17 131 ± 20 131 ± 20 130 ± 18 130 ± 16 
Central aortic 
systolic pressure 
(mmHg) 
120 ± 20 118 ± 22 118 ± 20 118 ± 23 118 ± 23 116 ± 22 117 ± 21 
Subendocardial 
viability ratio 
index (%) 
173 ± 16 168 ± 19 174 ± 26 170 ± 16 176 ± 21 172 ± 25 172 ± 24 
Augmentation 
index @HR75 (%) 
9 ± 12 5 ± 14 8 ± 13 6 ± 14 5 ± 14 4 ± 15 8 ± 11 
Resting 
metabolism 
       
Resting metabolic 
rate (kcal/min) 
1.24 ± 0.17 1.29 ± 0.07 1.35 ± 0.11 1.35 ± 0.16 1.36 ± 0.11 1.38 ± 0.16 1.36 ± 0.13 
Resting energy 
expenditure 
(kcal/day) 
1787 ± 252 1852 ± 105 1945 ± 151 1949 ± 224 1952 ± 161 1983 ± 237 1959 ± 193 
Lipid oxidation 
rate (g/min) 
0.06 ± 0.03 0.06 ± 0.02 0.07 ± 0.02 0.06 ± 0.03 0.07 ± 0.03 0.07 ± 0.03 0.04 ± 0.02 
 
Table 2. Blood metabolites and insulin, hemodynamic parameters and resting metabolism measured at baseline, 
post 24, 48 and 72 h after both aerobic interval (AI) and continuous moderate-intensity (CME) exercise trials. No 
significant differences in these variables were detected after either trial. 
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4.2 Anthropometric measurements 
Participants’ body composition remained similar to baseline at the end of the 
study. Lean mass, fat mass, fat-free mass, body fat percentage and bone mineral content 
were similar to baseline (Table 1). 
Both exercise trials did not elicit any statistically significant effect on 
anthropometrical measurements or body composition (Table 1). 
4.3 Blood metabolites and insulin resistance 
Both exercise trials did not significantly change fasting plasma glucose, insulin, 
triglycerides, total cholesterol, HDL and LDL. Furthermore, HOMA2-IR index was not 
significantly different after either exercise trials. The data for these variables is presented 
in Table 2. 
4.4 Salivary Cortisol  
Preliminary examination of absolute salivary cortisol response (Figure 3A) 
showed there was a main effect of trial on salivary cortisol with greater concentration 
observed in the AI trial compared to CME trial (10.06 ± 1.4 vs. 6.17 ± 1.0 nmol/L, p < 
0.05). There was also a main effect of time with absolute salivary cortisol increasing 
from baseline in both trials (Baseline: 6.05 ± 0.67, post 10: 8.71 ± 1.36, and post 30: 
9.59 ± 1.39, p < 0.05). There was no significant interaction between both exercise trials 
and time points. However, when salivary cortisol was expressed as a percentage relative 
to baseline level (Figure 3B); it was greater than baseline at 30 post exercise trial (189 ± 
35%, p < 0.05) however no significant trial or interaction effects were observed.   
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Figure 3. Absolute salivary cortisol (A) and salivary cortisol presented as percentage change from 
baseline (B) measured at post 10 and post 30 min after bouts of aerobic interval, (AI) and continuous 
moderate-intensity (CME) exercise. No significant interaction effects between trials and time points were 
observed in both A and B. 
*
 denotes significance (p   0.0 ) between trials. † denotes significance (p < 
0.05) between time points. (see text for further illustrations) 
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4.5 Resting hemodynamic parameters 
There was a main effect for trial and time in resting brachial diastolic BP (DBP). 
Resting brachial DBP was lower in the AI trial, compared with the CME trial (AI: 82 ± 5 
vs. CME: 84 ± 5 mmHg, p < 0.05) (Figure 4A). Compared with baseline, resting 
brachial DBP was lower at 24 h (baseline vs. 24 h: 86 ± 4 vs. 83 ± 5 mmHg, p < 0.05) 
and 72 h (baseline vs. 72 h: 86 ± 4 vs. 82 ± 5 mmHg, p < 0.05) post exercise, in both AI 
and CME trials. No significant interaction effects were observed for resting brachial 
DBP (p = 0.07). There was a main effect for trial and time for resting brachial mean 
arterial pressure (MAP). Resting brachial MAP was lower in the AI trial, compared with 
the CME trial (AI: 98 ± 6 vs. CME: 100 ± 5 mmHg, p < 0.05) (Figure 4B). Resting 
brachial MAP was lower compared with baseline at 24 h (baseline vs. 24 h: 102 ± 5 vs. 
99 ± 6  mmHg, p < 0.05), 48 h (baseline vs. 48 h: 102 ± 5 vs. 98 ± 6 mmHg, p < 0.05) 
and 72 h (baseline vs. 72 h: 102 ± 5 vs. 98 ± 6 mmHg, p < 0.05) post exercise, in both 
AI and CME trials. No significant interaction effects were observed for resting brachial 
MAP (p = 0.07). There was a main effect for trial and time for derived resting aortic 
diastolic BP (CDBP). Derived resting CDBP was lower in the AI trial, compared with 
the CME trial (AI: 83 ± 5 vs. CME: 85 ± 5 mmHg, p < 0.05) (Figure 4C). Compared 
with baseline, derived resting CDBP was lower at 24 h (baseline vs. 24 h: 87 ± 4 vs. 83 
± 5 mmHg, p < 0.05) and 72 h (baseline vs. 72 h: 87 ± 4 vs. 82 ± 5 mmHg, p < 0.05) 
post exercise, in both AI and CME trials. No significant interaction effects were 
observed for resting CDBP (p = 0.10). There was a main effect for trial and time for 
derived resting mean aortic pressure (CMAP). Derived resting CMAP was lower in the 
AI trial, compared with the CME trial (AI: 98 ± 6 vs. CME: 100 ± 5 mmHg, p < 0.05) 
(Figure 4D). Compared with baseline, derived resting CMAP was lower at 24 h 
(baseline vs. 24 h: 102 ± 5 vs. 99 ± 6  mmHg, p < 0.05), 48 h (baseline vs. 48 h: 102 ± 5 
vs. 98 ± 6 mmHg, p < 0.05), 72 h (baseline vs. 72 h: 102 ± 5 vs. 98 ± 6 mmHg, p < 0.05) 
post exercise, in both AI and CME trials. There was a trend towards interaction effects 
for derived resting CMAP, however significance was not reached (p = 0.063). There 
were no significant changes to other resting hemodynamic parameters such as resting 
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HR, both resting brachial and derived central systolic blood pressure and both SEVR 
and Alx@HR75 indexes (Table 2).  
 
 
 
 
 
 
  
B
as
el
in
e
P
os
t 2
4 
h
P
os
t 4
8 
h
P
os
t 7
2 
h
50
60
70
80
90
100
110
CME
AI
A
*
† †
R
e
s
ti
n
g
 b
r
a
c
h
ia
l 
d
ia
s
to
li
c
 b
lo
o
d
 p
r
e
s
s
u
r
e
 (
m
m
H
g
)
B
as
el
in
e
P
os
t 2
4 
h
P
os
t 4
8 
h
P
os
t 7
2 
h
70
80
90
100
110
120
130
CME
AI
B
*
† † †
R
e
s
ti
n
g
 b
r
a
c
h
ia
l 
m
e
a
n
 a
r
te
r
ia
l 
p
r
e
s
s
u
r
e
 (
m
m
H
g
)
B
as
el
in
e
P
os
t 2
4 
h
P
os
t 4
8 
h
P
os
t 7
2 
h
60
70
80
90
100
110
CME
AI
C
*
† †
D
e
r
iv
e
d
 r
e
s
ti
n
g
 a
o
r
ti
c
 d
ia
s
to
li
c
 p
r
e
s
s
u
r
e
 (
m
m
H
g
)
B
as
el
in
e
P
os
t 2
4 
h
P
os
t 4
8 
h
P
os
t 7
2 
h
70
80
90
100
110
120
130
CME
AI
D
*
† † †
D
e
r
iv
e
d
 r
e
s
ti
n
g
 m
e
a
n
 a
o
r
ti
c
 p
r
e
s
s
u
r
e
 (
m
m
H
g
)
 
Figure 4. Resting brachial diastolic blood pressure (DBP; A), resting brachial mean arterial pressure (MAP; B), 
derived resting aortic diastolic BP (CDBP; C), derived resting mean aortic pressure (CMAP; D) measured at 
baseline, 24 h, 48 h and 72 h post exercise after bouts of aerobic interval, (AI) and continuous moderate-intensity 
(CME) exercise. No significant interaction effects between trials and time points were observed in A, B, C and D. * 
denotes significance (p   0.0 ) between trials. † denotes significance (p   0.0 ) at time point vs. baseline. (see text 
for further illustrations) 
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4.6 Resting metabolism and substrate utilisation 
Compared with baseline and 24 h post exercise, fasted state MCHO was higher at 
72 h post exercise (baseline vs. 72 h: 0.10 ± 0.02 vs. 0.16 ± 0.02 g/min, 24 h vs. 72 h: 
0.11 ± 0.01 vs. 0.16 ± 0.02 g/min, p < 0.05) in both trials (Figure 5). No significant 
interaction effects were observed for fasted state MCHO. There were no significant 
changes to resting metabolic rate, resting energy expenditure and lipid oxidation rate 
(Table 2). 
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Figure 5.  Fasted state resting CHO oxidation rate (MCHO) measured at baseline, 24 h, 48 
h and 72 h post exercise after bouts of aerobic interval, (AI) and continuous moderate-
intensity (CME) exercise, no significant trials and interaction effects were observed. † 
denotes significance (p < 0.05) at time point vs. baseline and post 24 h. 
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4.7 PACES scores 
Participants perceived greater enjoyment in the AI trial as reflected by the higher 
PACES score, compared with the CME trial (109 ± 13 vs. 96 ± 10, p < 0.05) (Figure 6) 
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Figure 6. The physical activity enjoyment scale (PACES) score awarded by participants 
immediately after bouts of bouts of aerobic interval, (AI) and continuous moderate-
intensity (CME) exercise. * denotes significance (P < 0.05) between trials. 
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CHAPTER FIVE  DISCUSSION 
There is currently an increase in the incidence of overweight and obesity in 
developed nations. Obesity can lead to an undesirable clustering of cardiometabolic risk 
factors leading to metabolic syndrome, which increases the risk of type 2 diabetes and 
cardiovascular diseases [127, 195]. Aerobic interval training has been suggested to be a 
prospective alternative to the time intensive continuous moderate-intensity exercise. 
While the health benefits conferred by long term aerobic interval exercise has been 
established in both the general and certain clinical populations, its acute physiological 
effects in overweight and obese individuals is not well known. Understanding these 
effects is important in the discrimination between training effects and/or the effects of 
the last/final exercise bout. Furthermore, while recreationally active individuals perceive 
greater enjoyment from an aerobic interval session compared to continuous moderate-
intensity exercise, perceived enjoyment between the two exercise modals does not differ 
in overweight individuals [2, 48]. In fact, recovery duration between work intervals may 
also negatively influence perceived enjoyment as previously reported [196]. Such 
information is likely to be important in improving exercise program adherence and 
further research is warranted on defining an optimal AIT protocol that does not 
compromise perceived enjoyment in this population.  
5.1 Study objectives and primary findings 
The main objectives of this study were to examine and compare: i) the acute 
physiological effects after a single bout of AI session versus a single bout of matched 
work and duration CME session on cardiometabolic risk factors such as anthropometric 
variables, blood metabolites and insulin levels and resting hemodynamic parameters and 
metabolism and substrate utilisation and finally, ii) the immediate cortisol response after 
a single AI session versus a single CME session and iii) to determine which of the two 
exercise modalities is perceived more enjoyable by overweight and obese individuals. 
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The primary findings from this study are as follows. While we found a difference 
in total work performed between exercise trials, it was an extremely small (i.e. 3.2 kJ) 
and therefore unlikely to be responsible for the observed physiological differences 
between conditions. Both AI and CME trials reduced resting brachial DBP, at post 24 h 
and 72 h after an acute session. The AI trial elicited a greater reduction in resting 
brachial DBP. Similarly, derived resting CDBP was lower at post 24 h and 72 h than 
baseline following AI and CME, however; AI had a more pronounced effect. Both 
resting brachial MAP and derived resting CMAP were reduced over post 24 h, 48 h and 
72 h following both CME and AI trials, however the effect was greater following the AI 
trial. Fasted-state MCHO was higher post 72 h versus baseline and post 24 h in both CME 
and AI trials. Despite HR being higher during the AI trial, RPE scores were similar 
throughout the trials, except at the 28 min time point. The increase in salivary cortisol at 
30 min post exercise was not different between AI and CME trials. Finally, PACES 
scores were significantly higher in the AI trial, indicating that overweight/obese 
individuals found the AI session to be more “enjoyable”. 
5.2 Hemodynamic parameters 
Raised blood pressure has been attributed to 13% of global mortality [4]. Indeed 
mortality from both stroke and ischemic heart disease doubles with every 20 mmHg 
increase in systolic or 10 mmHg increase in diastolic BP [197]. The pathophysiological 
link between abdominal obesity and cardiovascular diseases is well established. Obesity 
causes left ventricle remodelling, leading to ventricular dysfunction [198]. This can 
result in diastolic dysfunction (i.e. elevation of diastolic BP) which can happen 
independently, simultaneous or prior to systolic failure [198]. Indeed, it has been found 
that mean arterial, systolic and diastolic BP are robust predictors of cardiovascular 
disease in young men below the age of 50 years old [199, 200]. The cohort in our study 
had baseline brachial systolic and diastolic BP of 133 ± 17 mmHg and 86 ± 12 mmHg, 
respectively. Accordingly, they can be classified as pre-hypertensive (i.e. systolic BP: 
120 – 139 mmHg, diastolic BP: 80 – 89 mmHg) and are predisposed towards a greater 
risk of developing cardiovascular diseases [200]. 
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Within the present study we found that a single session of CME or AI can 
acutely reduce resting DBP, MAP, derived resting CDBP and CMAP for up to 72 h 
following exercise. Post exercise hypotension can be described by a transient decreased 
in blood pressure following an acute bout of exercise, which underlying mechanisms 
have yet to be determined [201]. The magnitude of this phenomenon is more 
pronounced and consistent in borderline hypertensive [202, 203] and hypertensive [156, 
204, 205] than in normotensive [206, 207] individuals [201]. While studies have found 
that such post exercise hypotension which can last up to more than 12 h [156, 201, 206, 
208], this is the first study to our knowledge that has observed such changes for up to 72 
h. However, since there was an absence of post exercise hypotension observed at 48 h 
post exercise, caution should be taken when interpreting these findings. Indeed, the 
variability of diastolic BP can be mediated by the participants’ emotional state [209]. It 
is also possible that participants may have intermittently slept during resting metabolic 
measurements, which could have lowered their BP [210-212].  
Previously, Ciolac et al. (2009) found that CME (i.e. 40 min at 60% of heart rate 
reserve) reduced both mean 24 h systolic (i.e. -2.6 ± 6.6 mmHg) and diastolic (i.e. -2.3 ± 
4.6 mmHg) BP post exercise and night time systolic and diastolic BP (i.e. -4.8 ± 6.4 
mmHg and -4.6 ± 5.2 mmHg, respectively). However, AI (i.e. 40 min of 1 min at 80% 
of heart rate reserve, 2 min at 50% of heart rate reserve) only reduced 24 h mean systolic 
BP post exercise and night time systolic BP (i.e. -2.8 ± 6.5 mmHg and -3.4 ± 7.2 mmHg, 
respectively) without any significant change in diastolic BP [156]. Within the present 
study both CME and AI were found to reduce BP. However, we observed a significant 
reduction in diastolic and mean arterial and aortic BP and not in resting systolic and 
derived systolic BP, which is somewhat contrary to previous studies [156, 206, 213]. 
Indeed, studies have reported an average reduction in systolic BP by 14 mmHg in 
borderline hypertensive populations [201]. However, since post-exercise hypotension is 
negatively correlated with BMI [214], the discrepancies between our study and others 
may partially be explained by difference in the sampled populations. Our participants 
had a mean BMI of 31 ± 3 kg/m
2
 while other studies have recruited participants with 
BMI of < 25 kg/m
2
 [206, 213]. Although, Taylor Tolbert et al. (2000) observed a 
decrease in 24 h mean systolic BP (i.e. -7.4 ± 1.8 mmHg) and which was lower up to  6 
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h after 4  min of running at     of   2max in older obese males [205]. Alternatively, a 
small sample size of 8 could have limited the ability to detect significance in the present 
study. Further research is needed to better understand the factors that influence post 
exercise alterations in BP in overweight and obese individuals. 
Results of the present study indicate that AI elicited a greater reduction in BP. 
These findings are supported by the study of Jones, Taylor, Lewis, George and Atkinson 
(2009) who reported that intermittent exercises exerts a more pronounced post-exercise 
hypotension effect compared with a single bout of isocaloric CME [213].  This suggests 
that AI may be considered as an alternative exercise intervention to CME in mitigating 
hypertension on a daily basis. However, more studies are required to examine blood 
pressure changes during AI and further substantiate our findings before 
recommendation. Taken together, these results have implications for the measurement 
and interpretation of post training changes in BP and exercise prescription for reducing 
risk for cardiovascular diseases. 
5.3 Blood metabolites, insulin, HOMA2-IR and resting metabolism 
Metabolic syndrome is usually characterised by dyslipidaemia and impaired 
glucose homeostasis, all of which increases cardiometabolic risks. Exercise is a cost-
effective intervention that can mitigate hyperglycaemia. In the present study however, 
we did not observe a significant change in HOMA2-IR, fasting insulin and glucose 
following either the AI or CME trials. These data indicate that both exercise protocols 
had little influence on acute insulin resistance fasting glucose homeostasis. Jarmurtas et 
al. (2006) reported that in overweight males, glucose, insulin and insulin resistance were 
not different from baseline at 24 h and 48 h after an acute bout of aerobic exercise (i.e. 
6   of   O2max for 45 min) [215]. Despite the difference in exercise intensity, our 
findings are also similar. Interestingly, Jarmurtas et al. (2006) detected a significant 
decrease in insulin and insulin resistance immediately post exercise [215]. Together with 
our findings, we can infer that while an acute bout of exercise can immediately reduce 
insulin and insulin resistance, both these variables will likely return to pre-exercise 
levels within 24 to 48 h after exercise. Contrary to this, a previous study found that 
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aerobic exercise (i.e.     of   O2peak for 45 min with two bouts of 2 min rest 
interspersed after every 15 min) is superior to an acute bout of sprint interval session in 
eliciting significant improvement in both the HOMA and composite whole-body insulin 
sensitivity indexes, 24 h after exercise [150]. Similarly, Whyte et al. (2010) found 
significant improvement in whole-body insulin sensitivity index following 2 weeks of 
SIT in overweight and obese participants. However, in this study this change did not 
persist beyond 24 h and therefore is likely to be associated with an acute change in 
insulin sensitivity resulting from the ‘last exercise bout’ effect. It is possible that 
differences between the present study and the findings of previous research are the result 
of differences in exercise protocols. In the present study participants performed matched 
work and duration bouts of AI and CME, whereas the aforementioned studies have 
performed exercise for longer durations at a high-intensity or shorter but at 
supramaximal intensities. As such, further research is needed in order to understand the 
acute effects of exercise intensity and duration on insulin sensitivity. 
In addition to improving insulin sensitivity, it has also been found that acute 
exercise can alter blood lipid profile. For instance, it was previously observed that in 
men with hypercholesterolemia, following acute bouts of isocaloric high (i.e.  0  of 
  O2max) and moderate (i.e.  0  of   O2max) intensity exercise bout, total and LDL (i.e. 
4%) dropped and subsequently rose (i.e. 5 – 8%) by 48 h [216]. In the similar study, 
triglycerides were lower at 24 h (i.e. -18%) and 48 h (i.e. -15%) and HDL rose (i.e. 8 – 
9%) following exercise bouts [216]. In another study, Cullinane, Siconolfi, Saritelli and 
Thompson (1982) also reported a decrease in triglycerides levels in both trained and 
sedentary individuals, although values did not reach statistical significance, after 1 h of 
exercise bout [217]. In our study, after removal of an outlier, triglycerides decreased 
over 24 to 72 h (Table 2), however, changes were not statistically significant. Likewise, 
neither AI nor CME significantly influenced HDL, LDL or total cholesterol. The small 
sample size in our study, could have limit the power to detect significance. Therefore, 
future study would need to take into account a larger sample population if they are 
examining the influence of exercise on lipid metabolites. 
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Impaired lipid oxidation is typically observed in obese individuals and exercise 
has been postulated to be an effective way in improving lipid oxidation in these 
individuals since previous studies have demonstrated increase lipid oxidation during 
post-exercise recovery in healthy adults [218, 219]. Indeed, two weeks of sprint interval 
training in obese individuals has been shown to increase lipid and decrease carbohydrate 
oxidation rates, however changes did not persist past 24 h, therefore, authors alluded that 
it may be due to the “last exercise bout” effect as opposed to being a training adaptation 
[1]. Therefore, if assuming that the change in substrate oxidation rates observed by 
Whyte et al. (2010) were “last exercise bout” effects, then their observations are contrary 
to our findings since we observed a significant increase in carbohydrate oxidation rate 
only at 72 h after the last exercise bout with no effect on lipid oxidation rate [1]. 
Exercise can acutely increase lipid oxidation rate. For instance, Warren, Howden, 
Williams, Fell and Johnson (2009) observed similar increase in lipid oxidation rate (i.e. 
over 90 min) and total fat oxidation between CME (i.e.  0 min at  0  of   2max) and 
AI (i.e.   min at       2max,   min at 30  of   2max) [74]. Our findings indicate that 
any increment in lipid oxidation rate will not last up to 24 h. In addition, previous 
studies have observed a significant shift towards greater carbohydrate oxidation rate,    
to  0 min post exercise (i.e.  0  of   O2max) in overweight boys and a pronounced 
increase in carbohydrate oxidation rate but not lipid oxidation after 16 weeks of aerobic 
(i.e.  0  of   O2max, 3 days per week) in obese women [220, 221]. Together with our 
findings, which are somewhat similar, it is plausible that in overweight and obese 
individuals, there is an exercise induced shift towards preferential carbohydrate 
utilisation which is independent of exercise intensity. Furthermore, we have shown that 
this can occur after an acute bout of exercise and can become evident 72 h later. Future 
studies examining exercise induce changes in substrate utilisation in overweight and 
obese individuals should take into account a longer observation period. 
Our observation that neither a single session of AI or CME has a significant 
effect on resting energy expenditure over 72 h is consistent with that observed in the 
study by Saris and Schrauwen (2004), who reported that either isocaloric low (i.e. 60 
min at 38% maximal aerobic power) or high (i.e. 2.5 min of 80% and 50% maximal 
aerobic power using 1:1 work to rest intervals) intensity protocols did not significantly 
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affect 24 h energy expenditure or respiratory quotient in obese men [222]. Together, 
these findings indicate that despite the high intensity bouts in AI, compared with a 
matched work and duration bout of CME, both exercise modalities do not affect energy 
expenditure and respiratory quotient 24 h following exercise in overweight and obese 
individuals. 
5.4 Cortisol response  
Glucocorticoids play an important role in facilitating substrate utilisation as an 
adaptive response when under either physical or emotional stress [39]. In this study, we 
examined and compared cortisol response over 30 min post exercise in overweight and 
obese individuals after they have performed a single bout of AI and CME on separate 
occasions. We measured cortisol response using salivary cortisol as it detects 
biologically active free fraction cortisol and is not limited by the saturation point of 
cortisol binding globulin (CBG), since exercise stress can raise absolute cortisol above 
CBG saturation point [223, 224]. Absolute cortisol was significantly greater in the AI 
trial and was significantly greater than baseline at 10 and 30 min post exercise in both 
AI and CME. However, since baseline cortisol in the AI trial was greater than the CME 
trial, we decided to analyse the change in cortisol relative to the baseline of each 
respective trial. We then observed that both an acute bout of CME and AI similarly 
elicited pronounced elevation of cortisol 30 min post exercise with no difference 
between protocols. It should also be noted that cortisol level was not significantly 
elevated at 10 min post exercise. Jamurtas et al. ( 006) reported that an acute bout of 
CME bout (i.e. 6   of   O2max for 45 min) in overweight males did not significantly 
affect cortisol levels immediately post exercise [215]. The CME protocol used in our 
study involved a lower intensity and shorter duration (i.e. 50% of PPO for 40 min) 
compared to the protocol employed by Jamurtas et al. (2006), yet we found significant 
increase in salivary cortisol levels 30 min post exercise. While it is plausible that 
measuring for serum cortisol may have affected the likelihood of detecting any 
significant changes due to its lower sensitivity, it is also likely that if cortisol was 
measured over a longer time period post exercise, the authors would have detected 
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significant fluctuations in cortisol levels. Furthermore, the findings from our study is 
consistent with that observed by Wong and Harber (2006) who reported that cortisol 
levels in obese individuals after performing an acute exercise bout (i.e. 30 min CME at 
power output corresponding to ventilatory threshold) were elevated over time, peaking 
significantly between approximately 30 to 50 min post exercise [45]. Therefore, we 
suggest that studies intending to examine exercise induced cortisol response should 
consider measuring for cortisol fluctuation over a time course of up to 30 min at least to 
allow for the delayed spike in cortisol response immediately post exercise. 
Exercise-induced cortisol response is predominantly mediated by exercise 
intensity and duration, specifically over extended duration [42]. When matched for work 
output (i.e. 120 – 180 kJ) and duration (i.e. 20 min) between exercise types, Vanhelder, 
Radomski, Goode and Casey (1985) reported that only both resistance exercise and 
intermittent cycling elicited pronounced increase in cortisol levels, while cortisol levels 
were not affected after continuous cycling [225]. Our findings are contrary to that of 
Vanhelder et al. (1985) such that both CME and AI trials elicited similar increases in 
cortisol levels [225]. Rudolph and Mcauley (2010) reported that RPE and post exercise 
cortisol responses are positively correlated while McGuigan, Egan and Foster (2004) 
observed that both salivary cortisol and RPE responses correctly reflect the prescribed 
exercise intensity of resistance training protocols [226, 227]. In our study, participants 
reported almost similar RPE responses except at the 28 min time point in both CME and 
AI trials. From this alternative perspective, we examined the mean exercise intensity of 
the AI trial, in accordance to Saltin, Essen and Pedersen (1976), and found that it is 48% 
of PPO [228]. This is close to the exercise intensity we prescribed for the CME (i.e. 50% 
of PPO) trial. Therefore, if exercise intensity modulates cortisol levels, the similarity in 
exercise intensity between protocols could explain why we did not find any difference in 
post exercise cortisol response between both trials.  
5.5 Perceived “enjoyment” of the exercise trials 
It is clear that despite significant differences in HR responses between CME and 
AI trials in the present study (Figure 2), participants’ ratings of perceived exertion did 
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not differ throughout the majority of the trials. Therefore, we can infer that the AI trial is 
well tolerated in obese or overweight individuals despite eliciting greater HR response in 
these individuals. Thereby, AI may provide an exercise mode that allows overweight or 
obese participants to train “comfortably” at higher exercise intensity intermittently. 
Furthermore, perceived enjoyment of activity collected from PACES questionnaire was 
significantly higher for the AI trial, indicating a preference for it over the CME trial. 
This is consistent with a recently published study, which also reported that recreationally 
active men preferred high-intensity interval (i.e. 3 min at  0    O2max, 3 min at  0  
  O2max) over continuous moderate-intensity (i.e.  0 min at  0    O2max) [2]. However 
in a study by Sim et al. (2014), authors reported that perceived enjoyment in overweight 
individuals did not differ between either AI (i.e.   min at  00    O2peak, 4 min at  0  
  O2peak) or CME (60    O2peak) [48]. We postulate that the disparity in findings could 
be due to the difference in mean exercise intensity between our AI protocol and that of 
Sim et al. (2014) (i.e. 48% PPO vs. 60%   O2peak), however further research is warranted 
to determine to AI protocols with different mean exercise intensities have a negative 
influence on perceived enjoyment in overweight and obese individuals [48]. 
Indeed, adherence to physical activity can be reduced in overweight or obese 
individuals when exercising at higher than preferred exercise intensity; however this 
study has corroborated with a previous finding that having lower intensity recover bouts 
interspersed between high-intensity work bouts can reduce perceived aversion of 
exercise [168]. The finding from this contributes to the literature by suggesting that AI is 
well tolerated in overweight and obese individuals and further substantiates previous 
anecdotal reports that high-intensity interval exercise is more preferred. These results 
have implications for the prescription of exercise in such populations. 
5.6 Limitations 
A major limitation of this study is its small sample size. A small sample due to 
pragmatic considerations such as both budget and time constraints would have decreased 
the power of the study. This holds true especially for blood metabolites and HOMA-IR2 
measured in this study, most of which the observed powers were less than 0.1 for 
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between trials analysis, which could partly explain the inconsistencies in detecting 
significant changes compared to previous studies. Furthermore, it has also resulting in 
the inability to detect interaction between the main effects, making interpretation of the 
results challenging. Therefore, future prospective studies should consider the use of a 
larger sample size.  In addition, the rationale for employing the AI protocol used in our 
study was so that it is tolerable and safe, since we recruited untrained and sedentary 
overweight and obese individuals to perform an acute bout of exercise. However as 
mentioned previously, this resulted in the mean exercise intensity of the AI and exercise 
intensity of the CME trials to be somewhat similar. This could have partly contributed to 
why we did not detect significant differences in many of the metabolic and health 
markers we measured. It is possible that greater differences in exercise intensity 
resulting from SI interval training or higher intensity AI are needed in order to observe 
substantial differences in physiological response compared to CME. As such, further 
research is warranted to determine if a higher mean exercise intensity in the AI trial 
could elicit greater changes in both health and metabolic markers in comparison to a 
lower exercise intensity CME protocol. 
5.7 Practical implications 
This study has attempted to elucidate the “last exercise bout” effect arising from 
a single session of CME and AI. Pertaining to the findings from this study, either CME 
or AI can elicit a “last exercise bout” effect on both diastolic or its derived central 
parameters and carbohydrate oxidation rate up to 72 h, therefore, future training studies 
should consider scheduling more than 72 h for post training measurements especially if 
both the abovementioned variables are measured. In addition, cortisol responses should 
be sampled over a time period of at least 30 min for an accurate determination of post 
exercise cortisol response. Furthermore, the findings in our study have corroborated with 
extant studies that RPE and post exercise salivary cortisol response can be used to 
determine the intensity of an exercise protocol. Most importantly, we have demonstrated 
that aerobic interval cycling is preferred over continuous moderate-intensity cycling and 
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thus can be prescribed as an alternative to these individuals, with the likelihood of 
possibly higher adherence rate. 
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